{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "NomicEmbeddings\n",
    "\n",
    "Rag with metadata\n",
    "\n",
    "Human in the loop\n",
    "\n",
    "--------------------"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "add database to google api\n",
    "\n",
    "utilities:   \n",
    "- patients DB creator\n",
    "\n",
    "steps:\n",
    "- Create Agents\n",
    "- Define tools\n",
    "- Create graph\n",
    "- Define Agent Nodes\n",
    "- Define Tool Node\n",
    "- Define Edge Logic\n",
    "- Define the Graph\n",
    "- show the graph\n",
    "- Invoke\n",
    "  \n",
    "- Human in the loop\n",
    "- Maximum number of steps\n",
    "- Helper Utilities"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# LLM Agents for Clinical Trial Management\n",
    "\n",
    "In this notebook, we develop an agent-based system to automate the management and analysis of clinical trial data, ensuring compliance with regulatory standards, and providing comprehensive reports for stakeholders. This pipeline also incorporate human-in-the-loop (HITL) and memory mechanisms to enhance functionality and accuracy."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Steps and Plan\n",
    "\n",
    "1. Define the Problem:\n",
    "\n",
    "Objective: Automate clinical trial data management, analysis, compliance checks, and reporting.\n",
    "\n",
    "Key Components: Data collection, data analysis, compliance verification, reporting, and human-in-the-loop interventions.\n",
    "\n",
    "2. Design the Architecture:\n",
    "**Agents:**\n",
    "Data Collection Agent: Gathers patient data, trial results, and other relevant information.\n",
    "\n",
    "Data Analysis Agent: Analyzes the collected data to generate reports on trial outcomes.\n",
    "\n",
    "Compliance Agent: Ensures all data and processes adhere to regulatory standards.\n",
    "\n",
    "Reporting Agent: Compiles and presents the analysis findings in comprehensive reports.\n",
    "\n",
    "Human-in-the-Loop: Integrate a review phase where human experts validate data analysis and compliance checks before final reporting.\n",
    "\n",
    "Memory: Utilize LangGraph’s memory capabilities to track the progress and history of each trial."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The Clinical Trial Matching Agent is designed to match patients wit\th suitable clinical trials based on their medical history, symptoms, and ongoing treatments. This application helps patients find relevant clinical trials they may be eligible for, improving their chances of accessing new treatments and contributing to medical research.\n",
    "\n",
    "\n",
    "1. Database Setup\n",
    "- SQLite Database: Create two databases:\n",
    "- Patients DB: Stores patient medical history, previous trials, and other relevant data.\n",
    "- Clinical Trials DB: Contains information about ongoing and upcoming clinical trials, including eligibility criteria.\n",
    "2. Agents and Tools\n",
    "- Patient Data Ingestion Agent: Retrieves patient data from the SQLite database or prompts the user to provide missing data.\n",
    "- Data Validation and Collection Loop: Ensures all required fields are collected using persistence.\n",
    "- Policy Compliance Agent: Cross-checks patient data with institutional policies.\n",
    "- Trial Vectorization Agent: Extracts and vectorizes recruiting trials for efficient search.\n",
    "- Trial Matching Agent: Forms prompts from patient data to search the vector database for potential trial matches.\n",
    "- Human-in-the-Loop (HIL) Agent: Presents top trial matches to the user for selection.\n",
    "- Persistence Mechanism: Allows the application to save and resume states, especially useful for collecting patient data and searching trials."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "import getpass\n",
    "import os\n",
    "\n",
    "\n",
    "def _set_if_undefined(var: str):\n",
    "    if not os.environ.get(var):\n",
    "        os.environ[var] = getpass.getpass(f\"Please provide your {var}\")\n",
    "\n",
    "\n",
    "_set_if_undefined(\"OPENAI_API_KEY\")\n",
    "_set_if_undefined(\"LANGCHAIN_API_KEY\")\n",
    "# _set_if_undefined(\"TAVILY_API_KEY\")\n",
    "\n",
    "# Optional, add tracing in LangSmith\n",
    "os.environ[\"LANGCHAIN_TRACING_V2\"] = \"true\"\n",
    "os.environ[\"LANGCHAIN_PROJECT\"] = \"Clinical Trial Management\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_openai import ChatOpenAI\n",
    "\n",
    "\n",
    "vstore_created = False\n",
    "trials_vstore_created = False\n",
    "trials_db_downloaded = False\n",
    "modelID = \"gpt-3.5-turbo\"\n",
    "n_retrieved_policies = 6\n",
    "# n_retries = 6\n",
    "n_retrieved_trials = 6\n",
    "\n",
    "model = ChatOpenAI(temperature = 0.0, model=modelID)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# import os\n",
    "\n",
    "# from dotenv import load_dotenv, find_dotenv\n",
    "# _ = load_dotenv(find_dotenv()) # read local .env file\n",
    "\n",
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\")\n",
    "\n",
    "import pprint\n",
    "# A function for printing nicely\n",
    "def nprint(text, indent=2):\n",
    "    pp = pprint.PrettyPrinter(indent=indent)\n",
    "    pp.pprint(text)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Creating the sample datasets"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Patients database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Sophia Smith', 'Daniel Garcia', 'James Martinez', 'Michael Garcia', 'John Martinez', 'James Thomas', 'Jane Thomas', 'Michael Wilson', 'Emma Davis', 'Emily Garcia']\n",
      "100\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>name</th>\n",
       "      <th>age</th>\n",
       "      <th>medical_history</th>\n",
       "      <th>previous_trials</th>\n",
       "      <th>trial_status</th>\n",
       "      <th>trial_completion_date</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Emma Brown</td>\n",
       "      <td>56</td>\n",
       "      <td>Arthritis</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>Michael Brown</td>\n",
       "      <td>74</td>\n",
       "      <td>anxiety disorder</td>\n",
       "      <td>Trial 2</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>John Martinez</td>\n",
       "      <td>44</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>Trial 6</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>Sophia Anderson</td>\n",
       "      <td>42</td>\n",
       "      <td>myeloid leukemia</td>\n",
       "      <td>Trial 6</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2024-03-09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>Oliver Davis</td>\n",
       "      <td>23</td>\n",
       "      <td>myeloid leukemia</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>6</td>\n",
       "      <td>Daniel Doe</td>\n",
       "      <td>46</td>\n",
       "      <td>myeloid leukemia</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>7</td>\n",
       "      <td>Daniel Martinez</td>\n",
       "      <td>43</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>Trial 18</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>8</td>\n",
       "      <td>Jane Davis</td>\n",
       "      <td>80</td>\n",
       "      <td>peritoneal cancer</td>\n",
       "      <td>Trial 15</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2022-11-09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>9</td>\n",
       "      <td>Alice Anderson</td>\n",
       "      <td>49</td>\n",
       "      <td>gastric cancer</td>\n",
       "      <td>Trial 3</td>\n",
       "      <td>Completed</td>\n",
       "      <td>2023-08-03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>10</td>\n",
       "      <td>Daniel Doe</td>\n",
       "      <td>38</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>Trial 14</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2023-04-29</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>11</td>\n",
       "      <td>Daniel Wilson</td>\n",
       "      <td>34</td>\n",
       "      <td>prostate cancer</td>\n",
       "      <td>Trial 17</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2022-12-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>12</td>\n",
       "      <td>Oliver Davis</td>\n",
       "      <td>68</td>\n",
       "      <td>soft tissue sarcoma</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>13</td>\n",
       "      <td>James Thomas</td>\n",
       "      <td>37</td>\n",
       "      <td>Hypertension</td>\n",
       "      <td>Trial 10</td>\n",
       "      <td>Completed</td>\n",
       "      <td>2023-10-06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>14</td>\n",
       "      <td>Oliver Martinez</td>\n",
       "      <td>75</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>15</td>\n",
       "      <td>Daniel Thomas</td>\n",
       "      <td>67</td>\n",
       "      <td>gastric cancer</td>\n",
       "      <td>Trial 3</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2024-03-09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>16</td>\n",
       "      <td>Jane Davis</td>\n",
       "      <td>62</td>\n",
       "      <td>ovarian cancer</td>\n",
       "      <td>Trial 3</td>\n",
       "      <td>Completed</td>\n",
       "      <td>2022-08-27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>17</td>\n",
       "      <td>Jane Anderson</td>\n",
       "      <td>23</td>\n",
       "      <td>lung cancer</td>\n",
       "      <td>Trial 15</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>18</td>\n",
       "      <td>Daniel Garcia</td>\n",
       "      <td>57</td>\n",
       "      <td>Chronic Pain</td>\n",
       "      <td>Trial 20</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2022-10-16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>19</td>\n",
       "      <td>Emma Brown</td>\n",
       "      <td>22</td>\n",
       "      <td>prostate cancer</td>\n",
       "      <td>Trial 13</td>\n",
       "      <td>Completed</td>\n",
       "      <td>2023-02-09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>20</td>\n",
       "      <td>Emily Smith</td>\n",
       "      <td>54</td>\n",
       "      <td>prostate cancer</td>\n",
       "      <td>Trial 5</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    patient_id             name  age      medical_history previous_trials  \\\n",
       "0            1       Emma Brown   56            Arthritis                   \n",
       "1            2    Michael Brown   74     anxiety disorder         Trial 2   \n",
       "2            3    John Martinez   44              Obesity         Trial 6   \n",
       "3            4  Sophia Anderson   42     myeloid leukemia         Trial 6   \n",
       "4            5     Oliver Davis   23     myeloid leukemia                   \n",
       "5            6       Daniel Doe   46     myeloid leukemia                   \n",
       "6            7  Daniel Martinez   43              Obesity        Trial 18   \n",
       "7            8       Jane Davis   80    peritoneal cancer        Trial 15   \n",
       "8            9   Alice Anderson   49       gastric cancer         Trial 3   \n",
       "9           10       Daniel Doe   38              Anxiety        Trial 14   \n",
       "10          11    Daniel Wilson   34      prostate cancer        Trial 17   \n",
       "11          12     Oliver Davis   68  soft tissue sarcoma                   \n",
       "12          13     James Thomas   37         Hypertension        Trial 10   \n",
       "13          14  Oliver Martinez   75    colorectal cancer                   \n",
       "14          15    Daniel Thomas   67       gastric cancer         Trial 3   \n",
       "15          16       Jane Davis   62       ovarian cancer         Trial 3   \n",
       "16          17    Jane Anderson   23          lung cancer        Trial 15   \n",
       "17          18    Daniel Garcia   57         Chronic Pain        Trial 20   \n",
       "18          19       Emma Brown   22      prostate cancer        Trial 13   \n",
       "19          20      Emily Smith   54      prostate cancer         Trial 5   \n",
       "\n",
       "   trial_status trial_completion_date  \n",
       "0                                      \n",
       "1       Ongoing                        \n",
       "2       Ongoing                        \n",
       "3     Withdrawn            2024-03-09  \n",
       "4                                      \n",
       "5                                      \n",
       "6       Ongoing                        \n",
       "7     Withdrawn            2022-11-09  \n",
       "8     Completed            2023-08-03  \n",
       "9     Withdrawn            2023-04-29  \n",
       "10    Withdrawn            2022-12-01  \n",
       "11                                     \n",
       "12    Completed            2023-10-06  \n",
       "13                                     \n",
       "14    Withdrawn            2024-03-09  \n",
       "15    Completed            2022-08-27  \n",
       "16      Ongoing                        \n",
       "17    Withdrawn            2022-10-16  \n",
       "18    Completed            2023-02-09  \n",
       "19      Ongoing                        "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from datetime import datetime, timedelta\n",
    "\n",
    "# Generate the sample data again for display\n",
    "columns = [\"patient_id\", \"name\", \"age\", \"medical_history\", \"previous_trials\", \"trial_status\", \"trial_completion_date\"]\n",
    "data = []\n",
    "\n",
    "import random\n",
    "\n",
    "# Given names and surnames\n",
    "names = [\"John\", \"Jane\", \"Alice\", \"Michael\", \"Emily\", \"Daniel\", \"Sophia\", \"James\", \"Emma\", \"Oliver\"]\n",
    "surnames = [\"Doe\", \"Smith\", \"Johnson\", \"Brown\", \"Davis\", \"Garcia\", \"Martinez\", \"Anderson\", \"Thomas\", \"Wilson\"]\n",
    "\n",
    "# Generate all possible unique combinations of names and surnames\n",
    "combinations = [(name, surname) for name in names for surname in surnames]\n",
    "\n",
    "# Shuffle the combinations to ensure randomness\n",
    "random.shuffle(combinations)\n",
    "\n",
    "# Select the first 100 unique combinations\n",
    "unique_names = combinations[:100]\n",
    "\n",
    "# Generate the full names\n",
    "full_names = [f\"{name} {surname}\" for name, surname in unique_names]\n",
    "\n",
    "# Display the first few full names for verification\n",
    "print(full_names[:10])\n",
    "\n",
    "# Optionally, you can also display all 100 unique full names\n",
    "# print(len(full_names))\n",
    "# unique entries of list full_names\n",
    "print(len(set(full_names)))\n",
    "\n",
    "\n",
    "import numpy as np\n",
    "import json\n",
    "\n",
    "with open('../../source_data/diseases_list.json', 'r') as file:\n",
    "        trial_diseases =  json.load(file)\n",
    "\n",
    "list_trial_diseases = list({disease for diseases in trial_diseases.values() for disease in diseases})\n",
    "\n",
    "other_medical_conditions = [\"Hypertension\", \"Diabetes\", \"Asthma\", \"Heart Disease\", \"Arthritis\",\n",
    "                      \"Chronic Pain\", \"Anxiety\", \"Depression\", \"Obesity\"]\n",
    "\n",
    "all_conditions = list(set(list_trial_diseases + other_medical_conditions))\n",
    "\n",
    "trial_statuses = [\"Completed\", \"Ongoing\", \"Withdrawn\"]\n",
    "\n",
    "def random_date(start, end):\n",
    "    return start + timedelta(days=random.randint(0, int((end - start).days)))\n",
    "\n",
    "# start_date must be 2 years before now\n",
    "start_date = datetime.now() - timedelta(days=365 * 2)\n",
    "# start_date = datetime(2020, 1, 1)\n",
    "\n",
    "# end_date must be a month before now\n",
    "end_date = datetime.now() - timedelta(days=10)\n",
    "# end_date = datetime(2023, 1, 1)\n",
    "\n",
    "for i in range(1, 101):\n",
    "    name = random.choice(full_names)\n",
    "    age = random.randint(20, 80)\n",
    "    medical_history = random.choice(all_conditions)\n",
    "    \n",
    "    if random.choice([True, False]):\n",
    "        previous_trials = f\"Trial {random.randint(1, 20)}\"\n",
    "        trial_status = random.choice(trial_statuses)\n",
    "        trial_completion_date = random_date(start_date, end_date).strftime('%Y-%m-%d')\n",
    "    else:\n",
    "        previous_trials = \"\"\n",
    "        trial_status = \"\"\n",
    "        trial_completion_date = \"\"\n",
    "    if trial_status == \"Ongoing\":\n",
    "        trial_completion_date = \"\"\n",
    "\n",
    "    data.append((i, name, age, medical_history, previous_trials, trial_status, trial_completion_date))\n",
    "\n",
    "df = pd.DataFrame(data, columns=columns)\n",
    "# save df to csv\n",
    "df.to_csv(\"patients.csv\", index=False)\n",
    "df.head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "100\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>patient_id</th>\n",
       "      <th>name</th>\n",
       "      <th>age</th>\n",
       "      <th>medical_history</th>\n",
       "      <th>previous_trials</th>\n",
       "      <th>trial_status</th>\n",
       "      <th>trial_completion_date</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Emma Brown</td>\n",
       "      <td>56</td>\n",
       "      <td>Arthritis</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>Michael Brown</td>\n",
       "      <td>74</td>\n",
       "      <td>anxiety disorder</td>\n",
       "      <td>Trial 2</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>John Martinez</td>\n",
       "      <td>44</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>Trial 6</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>Sophia Anderson</td>\n",
       "      <td>42</td>\n",
       "      <td>myeloid leukemia</td>\n",
       "      <td>Trial 6</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2024-03-09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>Oliver Davis</td>\n",
       "      <td>23</td>\n",
       "      <td>myeloid leukemia</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>6</td>\n",
       "      <td>Daniel Doe</td>\n",
       "      <td>46</td>\n",
       "      <td>myeloid leukemia</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>7</td>\n",
       "      <td>Daniel Martinez</td>\n",
       "      <td>43</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>Trial 18</td>\n",
       "      <td>Ongoing</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>8</td>\n",
       "      <td>Jane Davis</td>\n",
       "      <td>80</td>\n",
       "      <td>peritoneal cancer</td>\n",
       "      <td>Trial 15</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2022-11-09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>9</td>\n",
       "      <td>Alice Anderson</td>\n",
       "      <td>49</td>\n",
       "      <td>gastric cancer</td>\n",
       "      <td>Trial 3</td>\n",
       "      <td>Completed</td>\n",
       "      <td>2023-08-03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>10</td>\n",
       "      <td>Daniel Doe</td>\n",
       "      <td>38</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>Trial 14</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>2023-04-29</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   patient_id             name  age    medical_history previous_trials  \\\n",
       "0           1       Emma Brown   56          Arthritis            None   \n",
       "1           2    Michael Brown   74   anxiety disorder         Trial 2   \n",
       "2           3    John Martinez   44            Obesity         Trial 6   \n",
       "3           4  Sophia Anderson   42   myeloid leukemia         Trial 6   \n",
       "4           5     Oliver Davis   23   myeloid leukemia            None   \n",
       "5           6       Daniel Doe   46   myeloid leukemia            None   \n",
       "6           7  Daniel Martinez   43            Obesity        Trial 18   \n",
       "7           8       Jane Davis   80  peritoneal cancer        Trial 15   \n",
       "8           9   Alice Anderson   49     gastric cancer         Trial 3   \n",
       "9          10       Daniel Doe   38            Anxiety        Trial 14   \n",
       "\n",
       "  trial_status trial_completion_date  \n",
       "0         None                  None  \n",
       "1      Ongoing                  None  \n",
       "2      Ongoing                  None  \n",
       "3    Withdrawn            2024-03-09  \n",
       "4         None                  None  \n",
       "5         None                  None  \n",
       "6      Ongoing                  None  \n",
       "7    Withdrawn            2022-11-09  \n",
       "8    Completed            2023-08-03  \n",
       "9    Withdrawn            2023-04-29  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import os\n",
    "# import shutil\n",
    "import sqlite3\n",
    "\n",
    "import pandas as pd\n",
    "\n",
    "overwrite = True\n",
    "\n",
    "database_file = 'patients_database.db'\n",
    "df = pd.read_csv('patients.csv')\n",
    "if overwrite or not os.path.exists(database_file):\n",
    "    if os.path.exists(database_file):\n",
    "        os.remove(database_file)\n",
    "    conn = sqlite3.connect(database_file)\n",
    "    cursor = conn.cursor()\n",
    "    cursor.execute('''\n",
    "    CREATE TABLE IF NOT EXISTS patients (\n",
    "        patient_id INTEGER PRIMARY KEY,\n",
    "        name TEXT,\n",
    "        age INTEGER,\n",
    "        medical_history TEXT,\n",
    "        previous_trials TEXT,\n",
    "        trial_status TEXT,\n",
    "        trial_completion_date TEXT\n",
    "    )\n",
    "    ''')\n",
    "\n",
    "    # Insert DataFrame into SQLite table\n",
    "    df.to_sql('patients', conn, if_exists='append', index=False)\n",
    "\n",
    "    # Commit and close the connection\n",
    "    conn.commit()\n",
    "else:\n",
    "    conn = sqlite3.connect(database_file)\n",
    "    cursor = conn.cursor()\n",
    "\n",
    "query = 'SELECT * FROM patients'\n",
    "\n",
    "# Execute the query and fetch all results\n",
    "cursor.execute(query)\n",
    "rows = cursor.fetchall()\n",
    "\n",
    "# Optionally, you can get the column names\n",
    "column_names = [description[0] for description in cursor.description]\n",
    "\n",
    "# Convert the results to a Pandas DataFrame for better readability\n",
    "df = pd.DataFrame(rows, columns=column_names)\n",
    "print(len(df))\n",
    "\n",
    "# Display the DataFrame\n",
    "conn.close()\n",
    "\n",
    "db = database_file\n",
    "df.head(10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Clinical Trials database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Only trials with status recruiting are selected.\n",
      "The database for trials is saved to ../../data/trials_data.csv \n",
      " It has 30 rows.\n",
      "---- Sample 1 ----\n",
      "\n",
      "        Inclusion Criteria:\n",
      "\n",
      "          -  Histologically confirmed locally advanced gastric (primary endpoint includes proximal\n",
      "             and mid-body stomach) or esophagogastric adenocarcinoma; distal gastric (antral)\n",
      "             adenocarcinomas are eligible for enrolment but will not be included in the primary\n",
      "             analysis\n",
      "\n",
      "          -  Locally advanced disease as determined by endoscopic ultrasound (EUS) stage > primary\n",
      "             tumor (T) 3 and/or any T, lymph nodes (N)+ disease without metastatic disease (Mx)\n",
      "\n",
      "          -  All patients must have diagnostic laparoscopy with diagnostic washings for cytology;\n",
      "             both cytology positive and negative patients are eligible for enrolment, but only\n",
      "             cytology negative patients will be included in the primary analyses; gross peritoneal\n",
      "             disease is not eligible\n",
      "\n",
      "          -  Eastern Cooperative Oncology Group (ECOG) performance status =< 1\n",
      "\n",
      "          -  Eligible for surgery with curative intent\n",
      "\n",
      "          -  Absolute neutrophil count (ANC) >= 1250/ul\n",
      "\n",
      "          -  Hemoglobin >= 9 g/dL\n",
      "\n",
      "          -  Platelets >= 100,000/ul\n",
      "\n",
      "          -  Total bilirubin < 1.5 x upper limit of normal\n",
      "\n",
      "          -  Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate\n",
      "             transaminase (SGPT) < 2.5 x upper limit of normal for patients without liver\n",
      "             metastases OR SGOT and SGPT < 5 x upper limit of normal for patients with liver\n",
      "             metastases\n",
      "\n",
      "          -  Creatinine =< 1.5 x upper limit of normal\n",
      "\n",
      "          -  Measurable or non-measurable disease by Response Evaluation Criteria in Solid Tumor\n",
      "             (RECIST) 1.1 will be allowed\n",
      "\n",
      "          -  Women of child-bearing potential and men must agree to use adequate contraception\n",
      "             (hormonal or barrier method of birth control; abstinence) prior to study entry and for\n",
      "             the duration of study participation, up until 30 days after final study treatment;\n",
      "             should a woman become pregnant or suspect that she is pregnant while participating in\n",
      "             this study, she should inform her treating physician immediately\n",
      "\n",
      "          -  Patients taking substrates, inhibitors, or inducers of cytochrome P450, family 3,\n",
      "             subfamily A, polypeptide 4 (CYP3A4) should be encouraged to switch to alternative\n",
      "             drugs whenever possible, given the potential for drug-drug interactions with\n",
      "             irinotecan\n",
      "\n",
      "          -  Signed informed consent\n",
      "\n",
      "        Exclusion Criteria:\n",
      "\n",
      "          -  Previous or concurrent malignancy, except for adequately treated basal cell or\n",
      "             squamous cell skin cancer, in situ cervical cancer, or any other cancer for which the\n",
      "             patient has been previously treated and the lifetime recurrence risk is less than 30%\n",
      "\n",
      "          -  Inflammatory bowel disease that is uncontrolled or on active treatment (Crohn's\n",
      "             disease, ulcerative colitis)\n",
      "\n",
      "          -  Diarrhea, grade 1 or greater by the National Cancer Institute Common Terminology\n",
      "             Criteria for Adverse Events (NCI-CTCAE, version [v] 4.0)\n",
      "\n",
      "          -  Neuropathy, grade 2 or greater by NCI-CTCAE, v 4.0\n",
      "\n",
      "          -  Serious underlying medical or psychiatric illnesses that would, in the opinion of the\n",
      "             treating physician, substantially increase the risk for complications related to\n",
      "             treatment\n",
      "\n",
      "          -  Active uncontrolled bleeding\n",
      "\n",
      "          -  Pregnancy or breastfeeding\n",
      "\n",
      "          -  Major surgery within 4 weeks\n",
      "\n",
      "          -  Patients with any polymorphism in UGT1A1 other than *1 or *28 (e.g, *6) will be\n",
      "             allowed and treated as in the *28/*28 dosing group\n",
      "      \n",
      "---- Sample 2 ----\n",
      "\n",
      "        Inclusion Criteria:\n",
      "\n",
      "          1. Cytologically or histologically confirmed esophageal carcinoma;\n",
      "\n",
      "          2. ECOG performance status: 0-1;\n",
      "\n",
      "          3. No treatments prior to enrollment;\n",
      "\n",
      "          4. At least one measurable lesion on CT, MRI or esophageal barium exam;\n",
      "\n",
      "          5. Normal functions of heart, lung, liver, kidney and bone marrow;\n",
      "\n",
      "          6. Blood exams qualified for chemotherapy, which included hemoglobulin ≥9 g/dl,\n",
      "             neutrophil ≥1.5×109/L and platelet (PLT) ≥100×109/L, creatinine ≤1.5 UNL;\n",
      "\n",
      "          7. Informed consent signed.\n",
      "\n",
      "        Exclusion Criteria:\n",
      "\n",
      "          1. Prior treatments of chemotherapy or irradiation;\n",
      "\n",
      "          2. Poor bone marrow, liver and kidney functions, which would make chemotherapy\n",
      "             intolerable;\n",
      "\n",
      "          3. Contraindication for irradiation: complete obstruction of esophagus, deep esophageal\n",
      "             ulcer, fistula to mediastinum, or haematemesis;\n",
      "\n",
      "          4. Participating in other clinical trials;\n",
      "\n",
      "          5. Clinically significant and uncontrolled major medical conditions including but not\n",
      "             limited to: active uncontrolled infection, symptomatic congestive heart failure,\n",
      "             Unstable angina pectoris or cardiac arrhythmia, psychiatric illness/ social situation\n",
      "             that would limit compliance with study requirements; any medical condition, which in\n",
      "             the opinion of the study investigator places the subject at an unacceptably high risk\n",
      "             for toxicities;\n",
      "\n",
      "          6. The subject has had another active malignancy within the past five years except for\n",
      "             cervical cancer in site, in situ carcinoma of the bladder or non-melanoma carcinoma of\n",
      "             the skin.\n",
      "      \n",
      "---- Sample 3 ----\n",
      "\n",
      "        Inclusion Criteria:\n",
      "\n",
      "          1. Patients must have biopsy proven metastatic NSCLC (Stage IV).\n",
      "\n",
      "          2. Patients must have received first line chemotherapy, from 4-6 cycles, and achieved\n",
      "             stable disease or a partial response.\n",
      "\n",
      "          3. Patients receiving first-line erlotinib, gefitinib, or icotinib for EGFR\n",
      "             mutant-positive for 3 months and achieved stable disease, partial response or\n",
      "             completely response.\n",
      "\n",
      "          4. Age 18 to 75 years old.\n",
      "\n",
      "          5. Patients must have measurable disease at baseline.\n",
      "\n",
      "          6. The amount of metastatic focus <5.\n",
      "\n",
      "          7. ECOG score 0-2\n",
      "\n",
      "          8. Adequate normal organ and marrow function for TKI treatment and radiotherapy.\n",
      "\n",
      "          9. Patients must has sensitizing EGFR mutation (e.g. exon 19 deletion or exon 21 L858R)\n",
      "\n",
      "         10. Patients must provide written informed consent to participate in the study.\n",
      "\n",
      "        Exclusion Criteria:\n",
      "\n",
      "          1. Patients who previously received radiotherapy to the primary site.\n",
      "\n",
      "          2. Patient can't tolerate radiotherapy or targeted therapy;\n",
      "\n",
      "          3. Pregnant or nursing women\n",
      "      \n",
      "---- Sample 4 ----\n",
      "\n",
      "        Inclusion Criteria:\n",
      "\n",
      "          -  Osteoporotic patients\n",
      "\n",
      "        Exclusion Criteria:\n",
      "\n",
      "          -  none\n",
      "      \n"
     ]
    }
   ],
   "source": [
    "import sys\n",
    "module_dir = os.path.abspath('../../src')  # Gets the absolute path to the src directory\n",
    "sys.path.append(module_dir)\n",
    "from helper_functions import dataset_create_trials\n",
    "\n",
    "overwrite = True\n",
    "if trials_db_downloaded and not overwrite:\n",
    "    print(f'Trials database already downloaded and stored in {trials_path}')\n",
    "    df_trials = pd.read_csv(trials_path)\n",
    "else:\n",
    "    df_trials, trials_path = dataset_create_trials(status='recruiting')\n",
    "    trials_db_downloaded = True\n",
    "\n",
    "# print the ctriteria column value froom 4 random rows of the dataferam. use a for loop\n",
    "df_samples = df_trials.sample(4).reset_index(drop=True)\n",
    "for i in range(4):\n",
    "    print(f'---- Sample {i+1} ----')\n",
    "    print(df_samples.iloc[i]['criteria'])\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Tools"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_core.tools import tool\n",
    "from langchain_openai import ChatOpenAI\n",
    "\n",
    "def get_patient_data(patient_id: int) -> dict:\n",
    "    \"\"\"Fetch all fields for the patient based on the given patient_id as an integer.\n",
    "\n",
    "    Returns:\n",
    "        A dictionary containing the patient's medical history.        \n",
    "    \"\"\"\n",
    "\n",
    "    # config = ensure_config()  # Fetch from the context\n",
    "    # configuration = config.get(\"configurable\", {})\n",
    "    # patient_id = configuration.get(\"patient_id\", None)\n",
    "\n",
    "    # if not patient_id:\n",
    "    #     raise ValueError(\"No patient ID given.\")\n",
    "\n",
    "    conn = sqlite3.connect(db)\n",
    "    cursor = conn.cursor()    \n",
    "    query = 'SELECT * FROM patients WHERE patient_id=?'\n",
    "    cursor.execute(query, (patient_id,))\n",
    "    patient_data = cursor.fetchone()\n",
    "    # rows = cursor.fetchall()\n",
    "    column_names = [column[0] for column in cursor.description]\n",
    "    conn.close()\n",
    "    if patient_data is None:\n",
    "        return None\n",
    "    else:    \n",
    "        results = dict(zip(column_names, patient_data))    \n",
    "    return results\n",
    "\n",
    "\n",
    "def add_patient_data(patient_data: dict):    \n",
    "    \"\"\"Adds a new patient to the SQLite database.\"\"\"\n",
    "    \n",
    "    name = patient_data['name']\n",
    "    age = patient_data['age']\n",
    "    medical_history = patient_data['medical_history']\n",
    "    previous_trials = patient_data['previous_trials']\n",
    "    trial_status = patient_data['trial_status']\n",
    "    last_trial_dates = patient_data['last_trial_dates']\n",
    "\n",
    "    conn = sqlite3.connect(db)\n",
    "    cursor = conn.cursor()\n",
    "    \n",
    "    # Insert the new patient data into the database\n",
    "    cursor.execute('''\n",
    "    INSERT INTO patients (name, age, medical_history, previous_trials, trial_status, last_trial_dates)\n",
    "    VALUES (?, ?, ?, ?, ?, ?)\n",
    "    ''', (name, age, medical_history, previous_trials, trial_status, last_trial_dates))\n",
    "    \n",
    "    conn.commit()\n",
    "    conn.close()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'patient_id': 4, 'name': 'Sophia Anderson', 'age': 42, 'medical_history': 'myeloid leukemia', 'previous_trials': 'Trial 6', 'trial_status': 'Withdrawn', 'trial_completion_date': '2024-03-09'}\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'patient_id': 4,\n",
       " 'name': 'Sophia Anderson',\n",
       " 'age': 42,\n",
       " 'medical_history': 'myeloid leukemia',\n",
       " 'previous_trials': 'Trial 6',\n",
       " 'trial_status': 'Withdrawn',\n",
       " 'trial_completion_date': '2024-03-09'}"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sample_patient_id = 4\n",
    "patient_data = get_patient_data(sample_patient_id)\n",
    "print(patient_data)\n",
    "patient_data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## vectorstore for patients database\n",
    "\n",
    "local embedding via NomicEmbeddings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "WARNING:root:USER_AGENT environment variable not set, consider setting it to identify your requests.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "12\n"
     ]
    }
   ],
   "source": [
    "# from gpt4all import Embed4All\n",
    "# model_name = 'nomic-embed-text-v1.5.f16.gguf'\n",
    "# text = 'The quick brown fox jumps over the lazy dog'\n",
    "# # you can change it to cuda if you have available GPU\n",
    "# embedder = Embed4All(model_name, device='cpu')\n",
    "# output = embedder.embed(text)\n",
    "# print(len(output))\n",
    "\n",
    "import re\n",
    "\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain_community.document_loaders import WebBaseLoader\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_nomic.embeddings import NomicEmbeddings\n",
    "from langchain_community.document_loaders import UnstructuredMarkdownLoader\n",
    "from langchain_core.documents import Document\n",
    "\n",
    "\n",
    "urls = [\n",
    "#     # \"https://lilianweng.github.io/posts/2023-06-23-agent/\",\n",
    "    #  \"https://lilianweng.github.io/posts/2023-03-15-prompt-engineering/\",\n",
    "    # \"https://lilianweng.github.io/posts/2023-10-25-adv-attack-llm/\",\n",
    "    \"https://storage.googleapis.com/benchmarks-artifacts/travel-db/swiss_faq.md\"\n",
    "\n",
    "]\n",
    "\n",
    "markdown_path = \"../../source_data/instut_trials_policy.md\"\n",
    "# markdown_path = \"../../temp/swiss_faq.md\"\n",
    "\n",
    "with open(markdown_path, \"r\") as f:\n",
    "    policy_text = f.read()\n",
    "\n",
    "# loader = UnstructuredMarkdownLoader(markdown_path)\n",
    "# docs = loader.load()\n",
    "\n",
    "doc_splits = [\n",
    "    Document(page_content= txt, metadata={\"source\": markdown_path}) for txt in re.split(r\"(?=\\n###)\", policy_text)\n",
    "    ]\n",
    "\n",
    "# the title of markdown is not required in the split\n",
    "doc_splits = doc_splits[1:]    \n",
    "\n",
    "# docs = [WebBaseLoader(url).load() for url in urls]\n",
    "# docs_list = [item for sublist in docs for item in sublist]\n",
    "\n",
    "# text_splitter = RecursiveCharacterTextSplitter.from_tiktoken_encoder(\n",
    "    # chunk_size=250, chunk_overlap=0\n",
    "# )\n",
    "# doc_splits = text_splitter.split_documents(docs_list)\n",
    "print(len(doc_splits))\n",
    "doc_splits\n",
    "\n",
    "# Add to vectorDB\n",
    "# load the existing vectorstore from \"rag-chroma\"\n",
    "\n",
    "\n",
    "if vstore_created:\n",
    "    vectorstore.delete_collection()\n",
    "\n",
    "vectorstore = Chroma.from_documents(\n",
    "    documents=doc_splits,\n",
    "    collection_name=\"rag-chroma\",\n",
    "    embedding=NomicEmbeddings(model=\"nomic-embed-text-v1.5\",\n",
    "                              inference_mode='local'),\n",
    ")\n",
    "vstore_created = True\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6\n",
      "\n",
      "#### 3. **Previous Trial Participation**\n",
      "   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\n",
      "   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\n",
      "   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\n",
      "   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\n",
      "   - **Trial Outcomes**:\n",
      "     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\n",
      "     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       " Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       " Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       " Document(page_content='\\n#### 12. **Employment and Daily Responsibilities**\\n   - **Employment Impact**: Patients must disclose if participation in the trial could impact their employment or daily responsibilities significantly.\\n   - **Availability**: Patients must be available for all scheduled trial visits and assessments as required by the protocol, with minimal risk of missing appointments.', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       " Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus     \\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       " Document(page_content='\\n#### 8. **Travel Restrictions**\\n   - **Travel Requirements**: Patients must be able to travel to the trial site regularly for check-ups and monitoring without significant hardship or risk.\\n   - **Travel History**: Patients who have traveled to areas with active outbreaks of infectious diseases within the past 3 months are not eligible.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retriever = vectorstore.as_retriever(search_kwargs={\"k\": n_retrieved_policies})\n",
    "# question = \"policy about patient's past trials\"\n",
    "question = \"\\ntrial_completion_date: 2024-04-01\"\n",
    "docs_retrieved = retriever.get_relevant_documents(question)\n",
    "print(len(docs_retrieved))\n",
    "doc_txt = docs_retrieved[0].page_content\n",
    "print(doc_txt)\n",
    "docs_retrieved"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'patient_id': 4,\n",
       " 'name': 'Sophia Anderson',\n",
       " 'age': 42,\n",
       " 'medical_history': 'myeloid leukemia',\n",
       " 'previous_trials': 'Trial 6',\n",
       " 'trial_status': 'Withdrawn',\n",
       " 'trial_completion_date': '2024-03-09'}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# patient_data['medical_history'] = \"Chronic Pain, Pregnant\"\n",
    "sample_patient_id = 4\n",
    "patient_data = get_patient_data(sample_patient_id)\n",
    "# print(patient_data)\n",
    "# patient_data\n",
    "# patient_data['trial_completion_date'] = '2024-04-01'\n",
    "patient_data\n",
    "# date"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Vstore for trials"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "we just work on 3 main categories of cancer, lukemia, and mental health problems as a demo application.\n",
    "\n",
    "For a more proper application, this must be done with the help of domain specialists."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'nctid': 'NCT00715611', 'status': 'recruiting', 'diseases': \"['mesothelioma']\", 'disease_category': 'cancer', 'drugs': \"['pemetrexed and cisplatin or carboplatin']\"}\n"
     ]
    }
   ],
   "source": [
    "# from langchain.document_loaders import CSVLoader\n",
    "# file = '../../data/trials_data.csv'\n",
    "# df_trials = pd.read_csv(file)\n",
    "from helper_functions import disease_map\n",
    "\n",
    "trial_docs = []\n",
    "for i, row in df_trials.iterrows():\n",
    "    disease = disease_map(row['diseases'])\n",
    "    if disease == 'other_conditions':\n",
    "        continue\n",
    "    doc = Document(\n",
    "        page_content=row['criteria'],\n",
    "        metadata={\n",
    "            \"nctid\": row['nctid'],\n",
    "            \"status\": row['status'],\n",
    "            # \"why_stop\": row['why_stop'],\n",
    "            # \"label\": row['label'],\n",
    "            # \"phase\": row['phase'],\n",
    "            \"diseases\": str(row['diseases']),\n",
    "            \"disease_category\": disease[0],\n",
    "            \"drugs\": row['drugs'],            \n",
    "        }\n",
    "    )\n",
    "    trial_docs.append(doc)\n",
    "# trial_docs\n",
    "\n",
    "print(trial_docs[0].metadata)\n",
    "\n",
    "list_remove = set()\n",
    "for i, doc in enumerate(trial_docs):\n",
    "    if len(doc.page_content)>10000:\n",
    "        list_remove.add(i)\n",
    "        # print(doc.metadata)\n",
    "    if doc.metadata['disease_category'] == 'other_conditions':\n",
    "        list_remove.add(i)\n",
    "        # print(doc.metadata)\n",
    "# remove list_remove indexes from trial_docs\n",
    "trial_docs = [doc for i, doc in enumerate(trial_docs) if i not in list_remove]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "# print(len(trial_docs[11].page_content))\n",
    "# trial_docs.pop(11)\n",
    "\n",
    "if trials_vstore_created:\n",
    "    vectorstore_trials.delete_collection()\n",
    "\n",
    "vectorstore_trials = Chroma.from_documents(\n",
    "    documents=trial_docs,\n",
    "    collection_name=\"trials-chroma\",\n",
    "    embedding=NomicEmbeddings(model=\"nomic-embed-text-v1.5\",\n",
    "                              inference_mode='local'),\n",
    ")\n",
    "trials_vstore_created = True"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collection trials-chroma_all-mpnet-base-v2 is loaded, number of itmes: 18\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          -  Patients have provided a signed Informed Consent Form\\r\\n\\r\\n          -  ECOG performance status of 0-1\\r\\n\\r\\n          -  BMI ≥ 18.5\\r\\n\\r\\n          -  Age: 18-65 years old\\r\\n\\r\\n          -  Histologically confirmed diagnosis of metastatic pancreatic cancer\\r\\n\\r\\n          -  No prior palliative chemotherapy\\r\\n\\r\\n          -  Measurable disease in at least 1 diameter by CT scan or MRI as per RECIST 1.1 criteria\\r\\n\\r\\n          -  Life expectancy ≥ 3 months\\r\\n\\r\\n          -  Patient has adequate bone marrow and organ function\\r\\n\\r\\n               -  Absolute Neutrophil Count (ANC) ≥ 2.0 x 109/L\\r\\n\\r\\n               -  Platelets ≥ 90 x 109/L\\r\\n\\r\\n               -  Hemoglobin ≥ 90 g/L\\r\\n\\r\\n          -  Patient has adequate liver function\\r\\n\\r\\n               -  AST and ALT not more than 2.5 times ULN (not more than 5.0 times ULN if there is\\r\\n                  liver metastasis)\\r\\n\\r\\n               -  Serum bilirubin ≤ 1.2 x ULN\\r\\n\\r\\n          -  Creatinine ≤ 1.25 times ULN\\r\\n\\r\\n          -  Good compliance\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          -  Pregnant or lactating women\\r\\n\\r\\n          -  Brain metastasis or only with bone metastasis.\\r\\n\\r\\n          -  Patients with severe gastrointestinal hemorrhage which need frequent blood\\r\\n             transfusions.\\r\\n\\r\\n          -  Refuse to take appropriate contraceptive measures (including male patients).\\r\\n\\r\\n          -  Allergic to Oxaliplatin, Irinotecan, Leucovorin or 5-Fluorouracil.\\r\\n\\r\\n          -  Severe systemic disease out of control such as unstable or uncompensated respiratory,\\r\\n             cardiac, liver, renal diseases.\\r\\n\\r\\n          -  Patient has a concurrent malignancy or has a malignancy within 5 years of study\\r\\n             enrollment, (with the exception of non-melanoma skin cancer or cervical carcinoma in\\r\\n             situ).\\r\\n\\r\\n          -  Psychiatric illness that would prevent the patient from giving informed consent.\\r\\n\\r\\n          -  Patient is concurrently using other antineoplastic agent\\r\\n\\r\\n          -  Patient has used investigational antineoplastic agent within 4 weeks prior to entry.\\r\\n\\r\\n          -  Known HIV-positivity.\\r\\n\\r\\n          -  No history of chronic diarrhea, nausea or vomit.\\r\\n\\r\\n          -  No ≥ grade 2 sensory peripheral neuropathy.\\r\\n\\r\\n          -  A history of transmural myocardial infarction (within 6 months prior to entry),\\r\\n             congestive heart failure, and unstable angina.\\r\\n\\r\\n          -  Infectious disease or inflammation with body temperature ≥ 38 ℃.\\r\\n      ', metadata={'disease_category': 'cancer', 'diseases': \"['metastatic pancreatic cancer']\", 'drugs': \"['mfolfirinox']\", 'nctid': 'NCT02028806', 'status': 'recruiting'}),\n",
       " Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          1. Subject is at least 20 years of age.\\r\\n\\r\\n          2. Written and voluntary informed consent understood, signed and dated.\\r\\n\\r\\n          3. They must have refractory or progressive colorectal cancer for which there is no\\r\\n             further curative therapy available.\\r\\n\\r\\n          4. Subject able to adhere to the study visit schedule and other protocol requirements.\\r\\n\\r\\n          5. ECOG 0-2\\r\\n\\r\\n          6. At least one measurable lesion that can be accurately assessed by imaging or physical\\r\\n             examination at baseline and following up visits.\\r\\n\\r\\n          7. Must have a life expectancy of 3 months or more\\r\\n\\r\\n          8. Demonstrate adequate organ function\\r\\n\\r\\n          9. Negative urine or serum pregnancy test within 28 days of study treatment\\r\\n\\r\\n         10. Be willing to provide fresh tissue for biomarker analysis, and, based on the adequacy\\r\\n             of the tissue sample quality for assessment of biomarker status.\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          1. ECOG ≥ 3\\r\\n\\r\\n          2. History of malignancy in the last 5 years.\\r\\n\\r\\n          3. Subject has known historical or active infection with HIV, hepatitis B, or hepatitis\\r\\n             C.\\r\\n\\r\\n          4. Breast-feeding or pregnant female\\r\\n\\r\\n          5. Patients can not the administration of Folic acid or Vitamin B12.\\r\\n\\r\\n          6. Before treatment with Pemetrexed.\\r\\n\\r\\n          7. Patients who can not swallow oral medication.\\r\\n\\r\\n          8. The most recent treatment with the clinical trial for the drug for 14 days prior to\\r\\n             enrollment.\\r\\n\\r\\n          9. Systemic chemotherapy within three weeks after the administration of the last before\\r\\n             the test treatment, radiation therapy patients who had been administered.\\r\\n\\r\\n         10. Except for the hair loss, it is induced before cancer treatment, all of toxicity in\\r\\n             progress (> CTCAE1 grade).\\r\\n\\r\\n         11. Upper GI bleeding within registration before 4 weeks of Bowel obstruction or CTCAE3 or\\r\\n             4 grade.\\r\\n\\r\\n         12. Subject who experienced a recent myocardial infarction, including severe/unstable\\r\\n             angina pectoris, coronary/peripheral artery bypass graft, uncontrolled hypertension,\\r\\n             clinically significant cardiac dysrhythmia or clinically significant electrocardiogram\\r\\n             (ECG) abnormality, significant or uncontrolled cardiovascular disease CHF, and\\r\\n             cerebrovascular accident or transient ischemic attack, or seizure disorder in the past\\r\\n             year.\\r\\n      ', metadata={'disease_category': 'cancer', 'diseases': \"['colorectal cancer']\", 'drugs': \"['pemetrexed']\", 'nctid': 'NCT02588781', 'status': 'recruiting'}),\n",
       " Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          1. Cytologically or histologically confirmed esophageal carcinoma;\\r\\n\\r\\n          2. ECOG performance status: 0-1;\\r\\n\\r\\n          3. No treatments prior to enrollment;\\r\\n\\r\\n          4. At least one measurable lesion on CT, MRI or esophageal barium exam;\\r\\n\\r\\n          5. Normal functions of heart, lung, liver, kidney and bone marrow;\\r\\n\\r\\n          6. Blood exams qualified for chemotherapy, which included hemoglobulin ≥9 g/dl,\\r\\n             neutrophil ≥1.5×109/L and platelet (PLT) ≥100×109/L, creatinine ≤1.5 UNL;\\r\\n\\r\\n          7. Informed consent signed.\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          1. Prior treatments of chemotherapy or irradiation;\\r\\n\\r\\n          2. Poor bone marrow, liver and kidney functions, which would make chemotherapy\\r\\n             intolerable;\\r\\n\\r\\n          3. Contraindication for irradiation: complete obstruction of esophagus, deep esophageal\\r\\n             ulcer, fistula to mediastinum, or haematemesis;\\r\\n\\r\\n          4. Participating in other clinical trials;\\r\\n\\r\\n          5. Clinically significant and uncontrolled major medical conditions including but not\\r\\n             limited to: active uncontrolled infection, symptomatic congestive heart failure,\\r\\n             Unstable angina pectoris or cardiac arrhythmia, psychiatric illness/ social situation\\r\\n             that would limit compliance with study requirements; any medical condition, which in\\r\\n             the opinion of the study investigator places the subject at an unacceptably high risk\\r\\n             for toxicities;\\r\\n\\r\\n          6. The subject has had another active malignancy within the past five years except for\\r\\n             cervical cancer in site, in situ carcinoma of the bladder or non-melanoma carcinoma of\\r\\n             the skin.\\r\\n      ', metadata={'disease_category': 'cancer', 'diseases': \"['esophageal cancer', 's-1', 'radiotherapy']\", 'drugs': \"['s-1']\", 'nctid': 'NCT02716688', 'status': 'recruiting'}),\n",
       " Document(page_content=\"\\n        Key Inclusion Criteria:\\r\\n\\r\\n          -  Subject must be ≥18 years of age.\\r\\n\\r\\n          -  Subjects must have documented IDH1 R132 gene-mutated advanced hematologic malignancy\\r\\n             based on local or central evaluation.\\r\\n\\r\\n          -  Subjects must be amenable to serial bone marrow biopsies, peripheral blood sampling,\\r\\n             and urine sampling during the study.\\r\\n\\r\\n          -  Subjects must have ECOG PS of 0 to 2.\\r\\n\\r\\n          -  Platelet count ≥20,000/µL (Transfusions to achieve this level are allowed).\\r\\n\\r\\n          -  Subjects must have adequate hepatic function as evidenced by: Aspartate\\r\\n             aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP)\\r\\n             ≤3.0 × ULN, unless considered due to leukemic disease and serum total bilirubin ≤1.5 x\\r\\n             upper limit of normal (ULN), unless considered due to Gilbert's disease or leukemic\\r\\n             disease\\r\\n\\r\\n          -  Subjects must have adequate renal function as evidenced by a serum creatinine ≤2.0 ×\\r\\n             ULN or creatinine clearance >40mL/min based on Cockroft-Gault glomerular filtration\\r\\n             rate (GFR)\\r\\n\\r\\n          -  Subjects must be recovered from any clinically relevant toxic effects of any prior\\r\\n             surgery, radiotherapy, or other therapy intended for the treatment of cancer.\\r\\n\\r\\n          -  Female subjects with reproductive potential must have a negative serum pregnancy test\\r\\n             within 7 days prior to the start of therapy and on the first day of study drug\\r\\n             administration.\\r\\n\\r\\n        Key Exclusion Criteria:\\r\\n\\r\\n          -  Subjects who have undergone hematopoietic stem cell transplant (HSCT) within 60 days\\r\\n             of the first dose of AG-120, or subjects on immunosuppressive therapy post HSCT at the\\r\\n             time of screening, or with clinically significant graft-versus-host disease (GVHD).\\r\\n             (The use of a stable dose of oral steroids post HSCT and/or topical for ongoing skin\\r\\n             GVHD is permitted.)\\r\\n\\r\\n          -  Subjects who received systemic anticancer therapy or radiotherapy <14 days prior to\\r\\n             their first day of study drug administration. (Hydroxyurea is allowed prior to\\r\\n             enrollment and after the start of AG-120).\\r\\n\\r\\n          -  Subjects who received an investigational agent <14 days prior to their first day of\\r\\n             study drug administration.\\r\\n\\r\\n          -  Subjects who are pregnant or breastfeeding.\\r\\n\\r\\n          -  Subjects with an active severe infection or with an unexplained fever >38.5°C during\\r\\n             screening visits or on their first day of study drug administration (at the discretion\\r\\n             of the Investigator, subjects with tumor fever may be enrolled).\\r\\n\\r\\n          -  Subjects with New York Heart Association (NYHA) Class III or IV congestive heart\\r\\n             failure or LVEF <40% by echocardiogram (ECHO) or multi-gated acquisition (MUGA) scan\\r\\n             within approximately 28 days of C1D1.\\r\\n\\r\\n          -  Subjects with a history of myocardial infarction within the last 6 months of\\r\\n             screening.\\r\\n\\r\\n          -  Subjects with a known unstable or uncontrolled angina pectoris.\\r\\n\\r\\n          -  Subjects with a known history of severe and/or uncontrolled ventricular arrhythmias.\\r\\n\\r\\n          -  Subjects with known unstable or uncontrolled angina pectoris.\\r\\n\\r\\n          -  Subjects with heart-rate corrected QT (QTc) interval ≥450 ms or other factors that\\r\\n             increase the risk of QT prolongation or arrhythmic events.\\r\\n\\r\\n          -  Patients taking medications that are known to prolong the QT interval\\r\\n\\r\\n          -  Subjects with known infection with human immunodeficiency virus (HIV) or active\\r\\n             hepatitis B or C.\\r\\n\\r\\n          -  Subjects with clinical symptoms suggesting active central nervous system (CNS)\\r\\n             leukemia or known CNS leukemia. Evaluation of cerebrospinal fluid is only required if\\r\\n             there is a clinical suspicion of CNS involvement by leukemia during screening.\\r\\n\\r\\n          -  Subjects with immediately life-threatening, severe complications of leukemia such as\\r\\n             uncontrolled bleeding, pneumonia with hypoxia or shock, and/or disseminated\\r\\n             intravascular coagulation.\\r\\n      \", metadata={'disease_category': 'leukemia', 'diseases': \"['relapsed or refractory acute myeloid leukemia (aml)', 'untreated aml', 'other idh1-mutated positive hematologic malignancies', 'myelodysplastic syndromes']\", 'drugs': \"['ag-120']\", 'nctid': 'NCT02074839', 'status': 'recruiting'})]"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "from langchain.vectorstores import Chroma\n",
    "import chromadb\n",
    "import chromadb.utils.embedding_functions as embedding_functions\n",
    "\n",
    "DB_action = 'load'\n",
    "persist_directory = '../../chromadb'\n",
    "collection_name =\"trials-chroma_all-mpnet-base-v2\"\n",
    "embed_model_id = 'sentence-transformers/all-mpnet-base-v2'\n",
    "# embedding_function = HuggingFaceEmbeddings(model_name=embed_model_id)\n",
    "embedding_function = embedding_functions.SentenceTransformerEmbeddingFunction(model_name=\"all-mpnet-base-v2\")\n",
    "chroma_client = chromadb.PersistentClient(path=persist_directory)\n",
    "\n",
    "collection = chroma_client.get_collection(name=collection_name, embedding_function=embedding_function)\n",
    "\n",
    "if DB_action == 'create':\n",
    "    collection = chroma_client.create_collection(name=collection_name, embedding_function=embedding_function)\n",
    "    embedding_function = HuggingFaceEmbeddings(model_name=embed_model_id)\n",
    "    vectordb = Chroma.from_documents(documents=trial_docs, embedding=embedding_function,\\\n",
    "            persist_directory=persist_directory, collection_name=collection_name)\n",
    "    vectordb.persist()\n",
    "    vectordb = None\n",
    "\n",
    "embedding_function = HuggingFaceEmbeddings(model_name=embed_model_id)\n",
    "vectorstore_trials_mpnet = Chroma(persist_directory=persist_directory, collection_name=collection_name, embedding_function=embedding_function) \n",
    "print(f'Collection {collection_name} is loaded, number of itmes: {collection.count()}')\n",
    "\n",
    "retriever_rag = vectorstore_trials_mpnet.as_retriever(search_kwargs={\"k\": 4})\n",
    "retrieved_docs = retriever_rag.invoke('Which trial is suitable for a patient with cancer?')\n",
    "retrieved_docs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.chains.query_constructor.base import AttributeInfo\n",
    "from langchain.retrievers.self_query.base import SelfQueryRetriever\n",
    "\n",
    "metadata_field_info = [\n",
    "    AttributeInfo(\n",
    "        name=\"disease_category\",\n",
    "        description=\"Defines the disease group of patients related to this trial. One of ['cancer', 'leukemia', 'mental_health']\",\n",
    "        # description=\"The trial is for patients when their disease is related to this category. One of ['cancer', 'leukemia', 'mental_health']\",\n",
    "        type=\"string\",\n",
    "    ),\n",
    "    AttributeInfo(\n",
    "        name=\"drugs\",\n",
    "        description=\"List of drug names used in the trial\",\n",
    "        type=\"str\",\n",
    "    ),    \n",
    "]\n",
    "\n",
    "document_content_description = \"The list of patient conditions to include or exclude them from the trial\"\n",
    "retriever_trial_sq = SelfQueryRetriever.from_llm(\n",
    "    model,\n",
    "    vectorstore_trials,\n",
    "    # vectorstore_trials_mpnet,\n",
    "    document_content_description,\n",
    "    metadata_field_info\n",
    "    # enable_limit=True\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6\n",
      "cancer ['prostate cancer']\n",
      "cancer ['metastatic pancreatic cancer']\n",
      "cancer ['rectal cancer']\n",
      "cancer ['colorectal cancer']\n",
      "cancer ['pancreatic ductal adenocarcinoma']\n",
      "cancer ['stage iv non-small cell lung cancer']\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          -  Histologically confirmed metastatic or advanced prostate adenocarcinoma that has been\\r\\n             previously treated with docetaxel-based therapy and has progressed during treatment of\\r\\n             at least one hormonal therapy(prior docetaxel is not required for the safety cohort)\\r\\n\\r\\n          -  Two rising PSA levels greater than or equal to (>/=) 2 ng/mL measured >/= 1 week apart\\r\\n             or radiographic evidence of disease progression in soft tissue or bone\\r\\n\\r\\n          -  Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at screening\\r\\n\\r\\n          -  Adequate hematologic and organ function\\r\\n\\r\\n          -  Documented willingness to use an effective means of contraception\\r\\n\\r\\n          -  Safety cohort only: agreement to use CGM for first cycle of treatment\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          -  History of Type I or Type II diabetes mellitus requiring insulin; safety cohort:\\r\\n             patients who are receiving any pharmacologic treatment for diabetes are not eligible\\r\\n\\r\\n          -  New York Heart Association Class III or IV heart failure or Left ventricular ejection\\r\\n             fraction < 50% or ventricular arrhythmia requiring medication\\r\\n\\r\\n          -  Significant atherosclerotic disease, as evidenced by: unstable angina, history of\\r\\n             myocardial infarction within 6 months prior to Day 1, or cerebrovascular accident\\r\\n             within 6 months prior to Day 1\\r\\n\\r\\n          -  Active autoimmune disease that is not controlled by nonsteroidal anti-inflammatory\\r\\n             drugs or active inflammatory disease which requires immunosuppressive therapy\\r\\n\\r\\n          -  Clinically significant history of liver disease\\r\\n\\r\\n          -  History of adrenal insufficiency or hyperaldosteronism\\r\\n\\r\\n          -  Phase II only: Previous therapy for prostate cancer with 17\\r\\n             alpha-hydroxylase/C17,20-lyase inhibitors, including abiraterone\\r\\n\\r\\n          -  Phase II only: Previous treatment for prostate cancer with Protein kinase B\\r\\n             phosphatidylinositol 3 kinase and/or mammalian target of rapamycin inhibitors\\r\\n\\r\\n          -  Need for chronic corticosteroid therapy of >/= 20 mg of prednisone per day or an\\r\\n             equivalent dose of other anti inflammatory corticosteroids or immunosuppressant\\r\\n      ', metadata={'disease_category': 'cancer', 'diseases': \"['prostate cancer']\", 'drugs': \"['abiraterone', 'apitolisib', 'ipatasertib', 'placebo', 'prednisone', 'prednisolone']\", 'nctid': 'NCT01485861', 'status': 'recruiting'}),\n",
       " Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          -  Patients have provided a signed Informed Consent Form\\r\\n\\r\\n          -  ECOG performance status of 0-1\\r\\n\\r\\n          -  BMI ≥ 18.5\\r\\n\\r\\n          -  Age: 18-65 years old\\r\\n\\r\\n          -  Histologically confirmed diagnosis of metastatic pancreatic cancer\\r\\n\\r\\n          -  No prior palliative chemotherapy\\r\\n\\r\\n          -  Measurable disease in at least 1 diameter by CT scan or MRI as per RECIST 1.1 criteria\\r\\n\\r\\n          -  Life expectancy ≥ 3 months\\r\\n\\r\\n          -  Patient has adequate bone marrow and organ function\\r\\n\\r\\n               -  Absolute Neutrophil Count (ANC) ≥ 2.0 x 109/L\\r\\n\\r\\n               -  Platelets ≥ 90 x 109/L\\r\\n\\r\\n               -  Hemoglobin ≥ 90 g/L\\r\\n\\r\\n          -  Patient has adequate liver function\\r\\n\\r\\n               -  AST and ALT not more than 2.5 times ULN (not more than 5.0 times ULN if there is\\r\\n                  liver metastasis)\\r\\n\\r\\n               -  Serum bilirubin ≤ 1.2 x ULN\\r\\n\\r\\n          -  Creatinine ≤ 1.25 times ULN\\r\\n\\r\\n          -  Good compliance\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          -  Pregnant or lactating women\\r\\n\\r\\n          -  Brain metastasis or only with bone metastasis.\\r\\n\\r\\n          -  Patients with severe gastrointestinal hemorrhage which need frequent blood\\r\\n             transfusions.\\r\\n\\r\\n          -  Refuse to take appropriate contraceptive measures (including male patients).\\r\\n\\r\\n          -  Allergic to Oxaliplatin, Irinotecan, Leucovorin or 5-Fluorouracil.\\r\\n\\r\\n          -  Severe systemic disease out of control such as unstable or uncompensated respiratory,\\r\\n             cardiac, liver, renal diseases.\\r\\n\\r\\n          -  Patient has a concurrent malignancy or has a malignancy within 5 years of study\\r\\n             enrollment, (with the exception of non-melanoma skin cancer or cervical carcinoma in\\r\\n             situ).\\r\\n\\r\\n          -  Psychiatric illness that would prevent the patient from giving informed consent.\\r\\n\\r\\n          -  Patient is concurrently using other antineoplastic agent\\r\\n\\r\\n          -  Patient has used investigational antineoplastic agent within 4 weeks prior to entry.\\r\\n\\r\\n          -  Known HIV-positivity.\\r\\n\\r\\n          -  No history of chronic diarrhea, nausea or vomit.\\r\\n\\r\\n          -  No ≥ grade 2 sensory peripheral neuropathy.\\r\\n\\r\\n          -  A history of transmural myocardial infarction (within 6 months prior to entry),\\r\\n             congestive heart failure, and unstable angina.\\r\\n\\r\\n          -  Infectious disease or inflammation with body temperature ≥ 38 ℃.\\r\\n      ', metadata={'disease_category': 'cancer', 'diseases': \"['metastatic pancreatic cancer']\", 'drugs': \"['mfolfirinox']\", 'nctid': 'NCT02028806', 'status': 'recruiting'}),\n",
       " Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          -  Diagnosis of adenocarcinoma of the rectum\\r\\n\\r\\n          -  Age: 18-70 years old\\r\\n\\r\\n          -  Signed informed consent; able to comply with study and/or follow- up procedures\\r\\n\\r\\n          -  Stage of the primary tumor may be determined by ultrasound or MRI\\r\\n\\r\\n          -  Stage II (T3-4, N0 [N0 is defined as all imaged lymph nodes < 1.0 cm]) OR stage III\\r\\n             (T1-4, N1-2 [with the definition of a clinically positive lymph node being any node ≥\\r\\n             1.0 cm]\\r\\n\\r\\n          -  Tumor palpable by digital rectal exam OR accessible by proctoscope or sigmoidoscope\\r\\n\\r\\n          -  Distal border of the tumor must be located < 12 cm from the anal verge\\r\\n\\r\\n          -  Tumor amenable to curative resection\\r\\n\\r\\n          -  Adequate bone marrow, hepatic and renal function as assessed by the following\\r\\n             laboratory requirements conducted within 7 days of starting study treatment:\\r\\n\\r\\n          -  Leukocytes ≥ 3.0 x109/ L, absolute neutrophil count (ANC) ≥ 1.5 x109/ L, platelet\\r\\n             count ≥ 100 x109/ L, hemoglobin (Hb) ≥ 9g/ dL.\\r\\n\\r\\n          -  Total bilirubin ≤1.5 x the upper limit of normal (ULN).\\r\\n\\r\\n          -  Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 5 x ULN.\\r\\n\\r\\n          -  Alkaline phosphatase limit ≤ 5x ULN.\\r\\n\\r\\n          -  Amylase and lipase ≤ 1.5 x the ULN.\\r\\n\\r\\n          -  Serum creatinine ≤ 1.5 x the ULN.\\r\\n\\r\\n          -  Calculated creatinine clearance or 24 hour creatinine clearance ≥ 50 mL/ min.\\r\\n\\r\\n          -  No renal disease that would preclude study treatment or follow-up\\r\\n\\r\\n          -  ECOG status: 0～1\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          -  Hypersensitivity to fluorouracil, oxaliplatin or irinotecan.\\r\\n\\r\\n          -  No More than 4 weeks since prior participation in any investigational drug study\\r\\n\\r\\n          -  More than 4 weeks since prior participation in any investigational drug study\\r\\n\\r\\n          -  Clear indication of involvement of the pelvic side walls by imaging\\r\\n\\r\\n          -  With distant metastasis\\r\\n\\r\\n          -  History of invasive rectal malignancy, regardless of disease-free interval\\r\\n\\r\\n          -  Fertile patients must use effective contraception\\r\\n\\r\\n          -  Uncontrolled hypertension\\r\\n\\r\\n          -  Cardiovascular disease that would preclude study treatment or follow-up\\r\\n\\r\\n          -  Lack of upper gastrointestinal tract integrity or malabsorption syndrome，active upper\\r\\n             gastrointestinal tract bleeding\\r\\n\\r\\n          -  Synchronous colon cancer\\r\\n\\r\\n          -  Pregnant or nursing, Fertile patients do not use effective contraception\\r\\n\\r\\n          -  Other malignancy within the past 5 years except effectively treated squamous cell or\\r\\n             basal cell skin cancer, melanoma in situ, carcinoma in situ of the cervix, or\\r\\n             carcinoma in situ of the colon or rectum\\r\\n\\r\\n          -  No psychiatric or addictive disorders, or other conditions that, in the opinion of the\\r\\n             investigator, would preclude study participation\\r\\n\\r\\n          -  patients refused to signed informed consent.\\r\\n      ', metadata={'disease_category': 'cancer', 'diseases': \"['rectal cancer']\", 'drugs': \"['mfolfox6']\", 'nctid': 'NCT02887313', 'status': 'recruiting'}),\n",
       " Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          1. Subject is at least 20 years of age.\\r\\n\\r\\n          2. Written and voluntary informed consent understood, signed and dated.\\r\\n\\r\\n          3. They must have refractory or progressive colorectal cancer for which there is no\\r\\n             further curative therapy available.\\r\\n\\r\\n          4. Subject able to adhere to the study visit schedule and other protocol requirements.\\r\\n\\r\\n          5. ECOG 0-2\\r\\n\\r\\n          6. At least one measurable lesion that can be accurately assessed by imaging or physical\\r\\n             examination at baseline and following up visits.\\r\\n\\r\\n          7. Must have a life expectancy of 3 months or more\\r\\n\\r\\n          8. Demonstrate adequate organ function\\r\\n\\r\\n          9. Negative urine or serum pregnancy test within 28 days of study treatment\\r\\n\\r\\n         10. Be willing to provide fresh tissue for biomarker analysis, and, based on the adequacy\\r\\n             of the tissue sample quality for assessment of biomarker status.\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          1. ECOG ≥ 3\\r\\n\\r\\n          2. History of malignancy in the last 5 years.\\r\\n\\r\\n          3. Subject has known historical or active infection with HIV, hepatitis B, or hepatitis\\r\\n             C.\\r\\n\\r\\n          4. Breast-feeding or pregnant female\\r\\n\\r\\n          5. Patients can not the administration of Folic acid or Vitamin B12.\\r\\n\\r\\n          6. Before treatment with Pemetrexed.\\r\\n\\r\\n          7. Patients who can not swallow oral medication.\\r\\n\\r\\n          8. The most recent treatment with the clinical trial for the drug for 14 days prior to\\r\\n             enrollment.\\r\\n\\r\\n          9. Systemic chemotherapy within three weeks after the administration of the last before\\r\\n             the test treatment, radiation therapy patients who had been administered.\\r\\n\\r\\n         10. Except for the hair loss, it is induced before cancer treatment, all of toxicity in\\r\\n             progress (> CTCAE1 grade).\\r\\n\\r\\n         11. Upper GI bleeding within registration before 4 weeks of Bowel obstruction or CTCAE3 or\\r\\n             4 grade.\\r\\n\\r\\n         12. Subject who experienced a recent myocardial infarction, including severe/unstable\\r\\n             angina pectoris, coronary/peripheral artery bypass graft, uncontrolled hypertension,\\r\\n             clinically significant cardiac dysrhythmia or clinically significant electrocardiogram\\r\\n             (ECG) abnormality, significant or uncontrolled cardiovascular disease CHF, and\\r\\n             cerebrovascular accident or transient ischemic attack, or seizure disorder in the past\\r\\n             year.\\r\\n      ', metadata={'disease_category': 'cancer', 'diseases': \"['colorectal cancer']\", 'drugs': \"['pemetrexed']\", 'nctid': 'NCT02588781', 'status': 'recruiting'}),\n",
       " Document(page_content=\"\\n        Inclusion Criteria:\\r\\n\\r\\n          1. Histologically or cytologically confirmed metastatic pancreatic ductal adenocarcinoma\\r\\n             (Islet cell neoplasms or neuroendocrine carcinomas are excluded)\\r\\n\\r\\n          2. ≥ 18 years of age at the time of signing the informed consent document\\r\\n\\r\\n          3. ECOG 0-1\\r\\n\\r\\n          4. At least one measurable lesion according to recist v1.1\\r\\n\\r\\n          5. No prior palliative chemotherapy for the treatment of metastatic pancreatic cancer\\r\\n             (Prior treatment with 5-FU or gemcitabine administered as a radiation sensitizer in\\r\\n             the adjuvant setting is allowed if the treatment had been received at least 6 months\\r\\n             before enroll).\\r\\n\\r\\n          6. Adequate BM function: ANC ≥1.5 × 109/L; Platelet count ≥100,000/mm2 (100 × 109/L); Hb\\r\\n             (Hb) ≥9 g/dL.\\r\\n\\r\\n          7. Adequate liver and renal function (obtained ≤14 days prior to enroll): AST (SGOT), ALT\\r\\n             (SGPT) ≤2.5 × upper limit of normal range (ULN), unless liver metastases are clearly\\r\\n             present, then ≤5 × ULN is allowed; Total bilirubin 1.5 ≤ ULN; Serum creatinine within\\r\\n             normal limits or calculated clearance ≥ 60 mL/min/1.73 m2\\r\\n\\r\\n          8. Albumin level ≥ 3 g/dl\\r\\n\\r\\n          9. Subjects should be asymptomatic for jaundice prior to Cycle 1 Day 1\\r\\n\\r\\n         10. Subject with signed the Informed Consent Form (ICF) prior to participation in any\\r\\n             study-related activities.\\r\\n\\r\\n         11. Female of childbearing potential (FCBP) (defined as a sexually mature woman who (1)\\r\\n             has not undergone hysterectomy [the surgical removal of the uterus] or bilateral\\r\\n             oophorectomy [the surgical removal of both ovaries] or (2) has not been naturally\\r\\n             postmenopausal for at least 24 consecutive months [ie, has had menses at any time\\r\\n             during the preceding 24 consecutive months]) must:\\r\\n\\r\\n               -  Either commit to true abstinence or agree to the use of 2 physician-approved\\r\\n                  contraceptive methods (oral, injectable, or implantable hormonal contraceptive;\\r\\n                  tubal ligation; intra-uterine device; barrier contraceptive with spermicide; or\\r\\n                  vasectomized partner) while on IP; and for 3 months following the last dose of\\r\\n                  IP; and\\r\\n\\r\\n               -  Has a negative serum pregnancy test (β-hCG) result at screening\\r\\n\\r\\n         12. Male subjects must practice true abstinence or agree to use a condom during sexual\\r\\n             contact with a pregnant female or a female of childbearing potential while\\r\\n             participating in the study, during dose interruptions, and for 6 months following IP\\r\\n             discontinuation, even if he has undergone a successful vasectomy\\r\\n\\r\\n         13. Subject able to adhere to the study visit schedule and other protocol requirements.\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          1. Subject has known symptomatic brain metastases.\\r\\n\\r\\n          2. History of malignancy in the last 5 years.\\r\\n\\r\\n          3. Breast-feeding or pregnant female\\r\\n\\r\\n          4. Patients with plastic biliary stent (Metal biliary stents are allowed.)\\r\\n\\r\\n          5. Subject has active, uncontrolled bacterial, viral, or fungal infection(s) requiring\\r\\n             systemic therapy.\\r\\n\\r\\n          6. Subject has known historical or active infection with HIV, hepatitis B, or hepatitis\\r\\n             C.\\r\\n\\r\\n          7. Subject has undergone major surgery within 4 weeks prior to Cycle 1 Day 1 of treatment\\r\\n             in this study.\\r\\n\\r\\n          8. Subject who experienced a recent myocardial infarction, including severe/unstable\\r\\n             angina pectoris, coronary/peripheral artery bypass graft, uncontrolled hypertension,\\r\\n             clinically significant cardiac dysrhythmia or clinically significant electrocardiogram\\r\\n             (ECG) abnormality, significant or uncontrolled cardiovascular disease CHF, and\\r\\n             cerebrovascular accident or transient ischemic attack, or seizure disorder in the past\\r\\n             year.\\r\\n\\r\\n          9. Subject has a history of allergy or hypersensitivity to any of the study drugs\\r\\n\\r\\n         10. Subjects with history of connective tissue disorders (eg, lupus, scleroderma,\\r\\n             arteritis nodosa).\\r\\n\\r\\n         11. Subjects with a history of interstitial lung disease\\r\\n\\r\\n         12. Any other malignancy within 5 years prior to enrollment, with the exception of\\r\\n             adequately treated in-situ carcinoma of the prostate (Gleason score ≤ 7), cervix,\\r\\n             uteri, or nonmelanomatous skin cancer (all treatment of which should have been\\r\\n             completed 6 months prior to enrollment).\\r\\n\\r\\n         13. Patients has > Grade 1 pre-existing peripheral neuropathy (per CTCAE)\\r\\n\\r\\n         14. Subject has serious medical risk factors involving any of the major organ systems, or\\r\\n             serious psychiatric disorders, which could compromise the subject's safety or the\\r\\n             study data integrity.\\r\\n\\r\\n         15. Subject is enrolled in any other clinical protocol or investigational trial with an\\r\\n             interventional agent or assessments that may interfere with study procedures.\\r\\n\\r\\n         16. Subject is unwilling or unable to comply with study procedures\\r\\n\\r\\n         17. Any significant medical condition, laboratory abnormality, or psychiatric illness that\\r\\n             would prevent the subject from participating in the study.\\r\\n      \", metadata={'disease_category': 'cancer', 'diseases': \"['pancreatic ductal adenocarcinoma']\", 'drugs': \"['nab-paclitaxel', 'gemcitabine']\", 'nctid': 'NCT02426281', 'status': 'recruiting'}),\n",
       " Document(page_content=\"\\n        Inclusion Criteria:\\r\\n\\r\\n          1. Patients must have biopsy proven metastatic NSCLC (Stage IV).\\r\\n\\r\\n          2. Patients must have received first line chemotherapy, from 4-6 cycles, and achieved\\r\\n             stable disease or a partial response.\\r\\n\\r\\n          3. Patients receiving first-line erlotinib, gefitinib, or icotinib for EGFR\\r\\n             mutant-positive for 3 months and achieved stable disease, partial response or\\r\\n             completely response.\\r\\n\\r\\n          4. Age 18 to 75 years old.\\r\\n\\r\\n          5. Patients must have measurable disease at baseline.\\r\\n\\r\\n          6. The amount of metastatic focus <5.\\r\\n\\r\\n          7. ECOG score 0-2\\r\\n\\r\\n          8. Adequate normal organ and marrow function for TKI treatment and radiotherapy.\\r\\n\\r\\n          9. Patients must has sensitizing EGFR mutation (e.g. exon 19 deletion or exon 21 L858R)\\r\\n\\r\\n         10. Patients must provide written informed consent to participate in the study.\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          1. Patients who previously received radiotherapy to the primary site.\\r\\n\\r\\n          2. Patient can't tolerate radiotherapy or targeted therapy;\\r\\n\\r\\n          3. Pregnant or nursing women\\r\\n      \", metadata={'disease_category': 'cancer', 'diseases': \"['stage iv non-small cell lung cancer']\", 'drugs': \"['tki']\", 'nctid': 'NCT03595644', 'status': 'recruiting'})]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retriever_trials = vectorstore_trials.as_retriever(search_kwargs={\"k\": n_retrieved_trials})\n",
    "# question = trial_docs[trail_smp].page_content\n",
    "question = \"\"\"\n",
    "Which trials are relevant to patient who has adenocarcinoma illness?\n",
    "\"\"\"\n",
    "\n",
    "# question = f\"\"\"\n",
    "# Which trials are relevant to the patient with the following medical history?\\n\n",
    "# patient_profile: {patient_profile}\n",
    "# \"\"\"\n",
    "# nprint(question)\n",
    "\n",
    "# Which four trials are for patients with mental problem?\n",
    "# print(trial_docs[trail_smp].metadata['nctid'])\n",
    "# question = \"Inclusion Criteria:\\r\\n\\r\\n          1. Subject\"\n",
    "docs_retrieved = retriever_trials.get_relevant_documents(question)\n",
    "# docs_retrieved = retriever_trial_sq.get_relevant_documents(question)\n",
    "print(len(docs_retrieved))\n",
    "doc_txt = docs_retrieved[0].page_content[:]\n",
    "nctid = docs_retrieved[0].metadata['nctid']\n",
    "for doc in docs_retrieved:\n",
    "    diseases = doc.metadata['diseases']\n",
    "    disease_category = doc.metadata['disease_category']\n",
    "    print(disease_category, diseases)\n",
    "docs_retrieved"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "dummy : profile creator llm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'patient_id': 8,\n",
       " 'name': 'Jane Davis',\n",
       " 'age': 80,\n",
       " 'medical_history': 'peritoneal cancer',\n",
       " 'previous_trials': 'Trial 15',\n",
       " 'trial_status': 'Withdrawn',\n",
       " 'trial_completion_date': '2022-11-09'}"
      ]
     },
     "execution_count": 128,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def patient_data_to_string(patient_data):\n",
    "    return \" \\n \".join([f\"{key}: {value}\" for key, value in patient_data.items()])\n",
    "\n",
    "patient_id = 8\n",
    "patient_data = get_patient_data(patient_id)\n",
    "patient_data\n",
    "# keys_to_include = ['age', 'medical_history']\n",
    "# patient_data = {key: patient_data[key] for key in keys_to_include}\n",
    "\n",
    "# patient_medical_history = patient_data_to_string(patient_data)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('Patient Jane Davis, 80 years old, has a medical history of peritoneal '\n",
      " 'cancer. She has previously participated in Trial 15 but withdrew from the '\n",
      " 'trial. The trial completion date was November 9, 2022. Based on her medical '\n",
      " 'history, relevant medical trials for Jane may include those focusing on '\n",
      " 'peritoneal cancer treatments or supportive care for elderly cancer patients.')\n"
     ]
    }
   ],
   "source": [
    "from langchain_core.output_parsers import StrOutputParser\n",
    "from langchain.prompts import PromptTemplate\n",
    "parser = StrOutputParser()\n",
    "\n",
    "# def patient_data_to_string(patient_data):\n",
    "    # return \" \\n\".join([f\"{key}: {value}\" for key, value in patient_data.items()])\n",
    "\n",
    "prompt_profile = PromptTemplate(\n",
    "    template=\"\"\"\n",
    "    You are the Clinical Research Coordinator in the screening phase of a clinical trial. \n",
    "    Use the following patient data to write the patient profile for the screening phase.\n",
    "    The patient profile is a summary of patient information.\n",
    "    The patient profile also suggest relevant medical trials based on patient's medical history.\n",
    "    Write the patient profile in 3 to 4 sentences.\\n\\n\n",
    "    {patient_data}\"\"\",\n",
    "    input_variables=[\"patient_data\"],\n",
    ")\n",
    "# model = ChatOpenAI(temperature = 0.0, model=modelID)\n",
    "\n",
    "chain_profile = prompt_profile | model | parser\n",
    "# keys_to_include = ['age', 'medical_history']\n",
    "# patient_data = {key: patient_data[key] for key in keys_to_include}\n",
    "del patient_data['name']\n",
    "del patient_data['patient_id']\n",
    "patient_profile = chain_profile.invoke({'patient_data': patient_data})\n",
    "nprint(patient_profile)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('\\n'\n",
      " 'Which trials are relevant to the patient with the following medical '\n",
      " 'history?\\n'\n",
      " '\\n'\n",
      " 'patient_profile: Patient is a 42-year-old individual with a history of '\n",
      " 'myeloid leukemia. They are currently in the screening phase of a clinical '\n",
      " 'trial. Based on their medical history, relevant medical trials may include '\n",
      " 'those focused on leukemia treatments or targeted therapies for myeloid '\n",
      " 'leukemia.\\n')\n",
      "3\n",
      "leukemia ['myelodysplastic syndromes', 'chronic myelomonocytic leukemia', 'acute myeloid leukemia']\n",
      "leukemia ['relapsed or refractory acute myeloid leukemia (aml)', 'untreated aml', 'other idh1-mutated positive hematologic malignancies', 'myelodysplastic syndromes']\n",
      "leukemia ['adult acute myeloid leukemia with 11q23 (mll) abnormalities', 'adult acute myeloid leukemia with del(5q)', 'adult acute myeloid leukemia with inv(16)(p13;q22)', 'adult acute myeloid leukemia with t(15;17)(q22;q12)', 'adult acute myeloid leukemia with t(16;16)(p13;q22)', 'adult acute myeloid leukemia with t(8;21)(q22;q22)', 'recurrent adult acute lymphoblastic leukemia', 'recurrent adult acute myeloid leukemia', 'recurrent childhood acute lymphoblastic leukemia', 'recurrent childhood acute myeloid leukemia']\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(page_content=\"\\n        Inclusion Criteria:\\r\\n\\r\\n          1. Able to understand and comply with the study procedures, understand the risks involved\\r\\n             in the study, and provide written informed consent before the first study-specific\\r\\n             procedure; specifically able to comply with the PK assessment schedule during the\\r\\n             first 2 treatment cycles.\\r\\n\\r\\n          2. Men or women ≥18 years who are candidates to receive IV decitabine according to FDA or\\r\\n             European Medicines Agency (EMA) approved indications:\\r\\n\\r\\n               1. In North America: Participants with MDS previously treated or untreated with de\\r\\n                  novo or secondary MDS, including all French-American-British subtypes (refractory\\r\\n                  anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess\\r\\n                  blasts, refractory anemia with excess blasts in transformation, and chronic\\r\\n                  myelomonocytic leukemia [CMML]), and subjects with MDS International Prognostic\\r\\n                  Scoring System (IPSS) int-1, -2, or high-risk MDS.\\r\\n\\r\\n               2. In Europe: Participants with de novo or secondary AML, as defined by the World\\r\\n                  Health Organization (WHO) criteria, who are not candidates for standard induction\\r\\n                  chemotherapy.\\r\\n\\r\\n          3. Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.\\r\\n\\r\\n          4. Adequate organ function defined as follows:\\r\\n\\r\\n               1. Hepatic: Total or direct bilirubin ≤2 × upper limit of normal (ULN); aspartate\\r\\n                  transaminase/serum glutamic oxaloacetic transaminase (AST/SGOT) and alanine\\r\\n                  transaminase/serum glutamic pyruvic transaminase (ALT/SGPT) ≤2.5 × ULN.\\r\\n\\r\\n               2. Renal: serum creatinine ≤1.5 × ULN or calculated creatinine clearance or\\r\\n                  glomerular filtration rate >50 mL/min/1.73 m2 for subjects with creatinine levels\\r\\n                  above institutional normal.\\r\\n\\r\\n          5. No major surgery within 30 days of first study treatment.\\r\\n\\r\\n          6. Life expectancy of at least 3 months.\\r\\n\\r\\n          7. Women of child-bearing potential must not be pregnant or breastfeeding and must have a\\r\\n             negative pregnancy test at screening. Women of non-childbearing potential are those\\r\\n             who have had a hysterectomy or bilateral oophorectomy, or who have completed\\r\\n             menopause, defined as no menses for at least 1 year AND either age ≥65 years or\\r\\n             follicle-stimulating hormone levels in the menopausal range.\\r\\n\\r\\n          8. Subjects and their partners with reproductive potential must agree to use effective\\r\\n             contraceptive measures during the study and for 3 months after the last dose of study\\r\\n             treatment. Effective contraception includes methods such as oral contraceptives or\\r\\n             double-barrier method (eg, use of a condom AND diaphragm, with spermicide).\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          1. Prior treatment with more than 1 cycle of azacitidine or decitabine. Prior cytotoxic\\r\\n             chemotherapy for AML except for hydroxyurea to control high white blood cell (WBC)\\r\\n             counts.\\r\\n\\r\\n          2. Hospitalization for more than 2 days for documented febrile neutropenia, pneumonia,\\r\\n             sepsis, or systemic infection in the 30 days before screening.\\r\\n\\r\\n          3. Treatment with any investigational drug or therapy within 2 weeks of study treatment,\\r\\n             or 5 half-lives, whichever is longer, before the first dose of study treatment, or\\r\\n             ongoing clinically significant adverse events (AEs) from previous treatment.\\r\\n\\r\\n          4. Cytotoxic chemotherapy or prior azacitidine or decitabine within 4 weeks of first dose\\r\\n             of study treatment.\\r\\n\\r\\n          5. Concurrent MDS therapies, including lenalidomide, erythropoietin,\\r\\n             cyclosporine/tacrolimus, granulocyte-colony stimulating factor (G-CSF),\\r\\n             granulocyte-macrophage colony-stimulating factor, etc. (Prior treatment with these\\r\\n             agents is permitted, provided that completion is at least 1 week before the first dose\\r\\n             of study treatment.)\\r\\n\\r\\n          6. Poor medical risk because of other conditions such as uncontrolled systemic diseases,\\r\\n             active uncontrolled infections, or comorbidities that may put the patient at risk of\\r\\n             not being able to complete at least 2 cycles of treatment.\\r\\n\\r\\n          7. Known significant mental illness or other condition, such as active alcohol or other\\r\\n             substance abuse or addiction, that in the opinion of the investigator predisposes the\\r\\n             subject to high risk of noncompliance with the protocol.\\r\\n\\r\\n          8. Rapidly progressive or highly proliferative disease (total white blood cell count of\\r\\n             >15 × 10^9/L) or other criteria that render the subject at high risk of requiring\\r\\n             intensive cytotoxic chemotherapy within the next 3 months.\\r\\n\\r\\n          9. Life-threatening illness or severe organ system dysfunction, such as uncontrolled\\r\\n             congestive heart failure or chronic obstructive pulmonary disease, or other reasons\\r\\n             including laboratory abnormalities, which, in the investigator's opinion, could\\r\\n             compromise the subject's safety, interfere with the absorption or metabolism of\\r\\n             ASTX727, or compromise completion of the study or integrity of the study outcomes.\\r\\n\\r\\n         10. Prior malignancy, except for adequately treated basal cell or squamous cell skin\\r\\n             cancer, in situ cervical cancer, prostate cancer or breast cancer under control with\\r\\n             hormone therapy, or other cancer from which the subject has been disease free for at\\r\\n             least 2 years.\\r\\n      \", metadata={'disease_category': 'leukemia', 'diseases': \"['myelodysplastic syndromes', 'chronic myelomonocytic leukemia', 'acute myeloid leukemia']\", 'drugs': \"['astx727', 'dacogen']\", 'nctid': 'NCT03306264', 'status': 'recruiting'}),\n",
       " Document(page_content=\"\\n        Key Inclusion Criteria:\\r\\n\\r\\n          -  Subject must be ≥18 years of age.\\r\\n\\r\\n          -  Subjects must have documented IDH1 R132 gene-mutated advanced hematologic malignancy\\r\\n             based on local or central evaluation.\\r\\n\\r\\n          -  Subjects must be amenable to serial bone marrow biopsies, peripheral blood sampling,\\r\\n             and urine sampling during the study.\\r\\n\\r\\n          -  Subjects must have ECOG PS of 0 to 2.\\r\\n\\r\\n          -  Platelet count ≥20,000/µL (Transfusions to achieve this level are allowed).\\r\\n\\r\\n          -  Subjects must have adequate hepatic function as evidenced by: Aspartate\\r\\n             aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP)\\r\\n             ≤3.0 × ULN, unless considered due to leukemic disease and serum total bilirubin ≤1.5 x\\r\\n             upper limit of normal (ULN), unless considered due to Gilbert's disease or leukemic\\r\\n             disease\\r\\n\\r\\n          -  Subjects must have adequate renal function as evidenced by a serum creatinine ≤2.0 ×\\r\\n             ULN or creatinine clearance >40mL/min based on Cockroft-Gault glomerular filtration\\r\\n             rate (GFR)\\r\\n\\r\\n          -  Subjects must be recovered from any clinically relevant toxic effects of any prior\\r\\n             surgery, radiotherapy, or other therapy intended for the treatment of cancer.\\r\\n\\r\\n          -  Female subjects with reproductive potential must have a negative serum pregnancy test\\r\\n             within 7 days prior to the start of therapy and on the first day of study drug\\r\\n             administration.\\r\\n\\r\\n        Key Exclusion Criteria:\\r\\n\\r\\n          -  Subjects who have undergone hematopoietic stem cell transplant (HSCT) within 60 days\\r\\n             of the first dose of AG-120, or subjects on immunosuppressive therapy post HSCT at the\\r\\n             time of screening, or with clinically significant graft-versus-host disease (GVHD).\\r\\n             (The use of a stable dose of oral steroids post HSCT and/or topical for ongoing skin\\r\\n             GVHD is permitted.)\\r\\n\\r\\n          -  Subjects who received systemic anticancer therapy or radiotherapy <14 days prior to\\r\\n             their first day of study drug administration. (Hydroxyurea is allowed prior to\\r\\n             enrollment and after the start of AG-120).\\r\\n\\r\\n          -  Subjects who received an investigational agent <14 days prior to their first day of\\r\\n             study drug administration.\\r\\n\\r\\n          -  Subjects who are pregnant or breastfeeding.\\r\\n\\r\\n          -  Subjects with an active severe infection or with an unexplained fever >38.5°C during\\r\\n             screening visits or on their first day of study drug administration (at the discretion\\r\\n             of the Investigator, subjects with tumor fever may be enrolled).\\r\\n\\r\\n          -  Subjects with New York Heart Association (NYHA) Class III or IV congestive heart\\r\\n             failure or LVEF <40% by echocardiogram (ECHO) or multi-gated acquisition (MUGA) scan\\r\\n             within approximately 28 days of C1D1.\\r\\n\\r\\n          -  Subjects with a history of myocardial infarction within the last 6 months of\\r\\n             screening.\\r\\n\\r\\n          -  Subjects with a known unstable or uncontrolled angina pectoris.\\r\\n\\r\\n          -  Subjects with a known history of severe and/or uncontrolled ventricular arrhythmias.\\r\\n\\r\\n          -  Subjects with known unstable or uncontrolled angina pectoris.\\r\\n\\r\\n          -  Subjects with heart-rate corrected QT (QTc) interval ≥450 ms or other factors that\\r\\n             increase the risk of QT prolongation or arrhythmic events.\\r\\n\\r\\n          -  Patients taking medications that are known to prolong the QT interval\\r\\n\\r\\n          -  Subjects with known infection with human immunodeficiency virus (HIV) or active\\r\\n             hepatitis B or C.\\r\\n\\r\\n          -  Subjects with clinical symptoms suggesting active central nervous system (CNS)\\r\\n             leukemia or known CNS leukemia. Evaluation of cerebrospinal fluid is only required if\\r\\n             there is a clinical suspicion of CNS involvement by leukemia during screening.\\r\\n\\r\\n          -  Subjects with immediately life-threatening, severe complications of leukemia such as\\r\\n             uncontrolled bleeding, pneumonia with hypoxia or shock, and/or disseminated\\r\\n             intravascular coagulation.\\r\\n      \", metadata={'disease_category': 'leukemia', 'diseases': \"['relapsed or refractory acute myeloid leukemia (aml)', 'untreated aml', 'other idh1-mutated positive hematologic malignancies', 'myelodysplastic syndromes']\", 'drugs': \"['ag-120']\", 'nctid': 'NCT02074839', 'status': 'recruiting'}),\n",
       " Document(page_content='\\n        Inclusion Criteria:\\r\\n\\r\\n          -  Participant has the ability and the willingness to sign the informed consent document\\r\\n             (for adults only, for participants with mild cognitive abilities may use a legally\\r\\n             authorized representative)\\r\\n\\r\\n          -  Documented (signed) informed consent; the patient, family member and transplant staff\\r\\n             physician (physician, nurse, and social worker) meet at least once prior to starting\\r\\n             the transplant procedure; during this meeting all pertinent information with respect\\r\\n             to risks and benefits to donor and recipient will be presented; alternative treatment\\r\\n             modalities will be discussed; the risks are explained in detail in the enclosed\\r\\n             consent forms\\r\\n\\r\\n          -  Karnofsky performance status >= 70% =< 2\\r\\n\\r\\n          -  Acute lymphocytic leukemia or acute myelogenous leukemia who are not in first\\r\\n             remission or second remission i.e. after failing induction therapy, or in relapse or\\r\\n             beyond second remission; (prior therapy with VP-16 and Cytoxan is allowed)\\r\\n\\r\\n          -  All candidates for this study must have a human leukocyte antigen (HLA) (A, B, C, DR)\\r\\n             identical siblings who is willing to donate bone marrow or primed blood stem cells or\\r\\n             a 10/10 allele matched unrelated donor; a single allele mismatch at A, B, C, DR or DQ\\r\\n             and a killer immunoglobulin-like receptor (KIR) mismatch at C will be allowed; all ABO\\r\\n             blood group combinations of the donor/recipient are acceptable\\r\\n\\r\\n          -  The time from the end last induction, re-induction, or consolidation regimen should be\\r\\n             greater than or equal to 14 days from planned start of study treatment; Note:\\r\\n             Chemotherapy given within 14 days of planned study enrollment for the purpose of\\r\\n             controlling counts is permitted\\r\\n\\r\\n          -  Total bilirubin =< 1.5 x upper limit of normal (ULN) OR 3 x ULN for Gilbert\\'s disease\\r\\n\\r\\n          -  Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate\\r\\n             transaminase (SGPT) =< 5 x ULN\\r\\n\\r\\n          -  Measured creatinine clearance >= 80 ml/min per 24 hour urine collection OR serum\\r\\n             creatinine =< 1.3 mg/dL\\r\\n\\r\\n          -  Women of child bearing potential only: Negative urine or serum pregnancy test\\r\\n\\r\\n          -  Pulmonary function tests: Forced expiratory volume in one second (FEV1) and carbon\\r\\n             monoxide diffusion capacity (DLCO) (adjusted for Hb) >= 50% adjusted of predicted\\r\\n             normal value\\r\\n\\r\\n          -  Echocardiogram (ECHO) or multi gated acquisition scan (MUGA): ejection fraction of >=\\r\\n             50% AND no finding of abnormal wall motion (i.e. report does not indicate that wall\\r\\n             motion is \"abnormal\" or \"altered\")\\r\\n\\r\\n          -  Electrocardiogram (EKG) showing no ischemic changes and no abnormal rhythm\\r\\n\\r\\n          -  Agreement of men AND women-of-child-bearing-potential to use adequate contraception\\r\\n             (hormonal or barrier method of birth control or abstinence) prior to study entry and\\r\\n             for six months following duration of study participation; should a woman become\\r\\n             pregnant or suspect that she is pregnant while participating on the trial, she should\\r\\n             inform her treating physician immediately\\r\\n\\r\\n          -  DONOR ELIGIBILITY: Donor evaluation and eligibility will be assessed as per current\\r\\n             City of Hope standard operating procedure (SOP)\\r\\n\\r\\n        Exclusion Criteria:\\r\\n\\r\\n          -  Prior autologous or allogeneic hematopoietic stem cell\\r\\n\\r\\n          -  Prior radiation therapy that would exclude the use of TMLI\\r\\n\\r\\n          -  Plans during the trial to receive any other (non-trial) investigational agents, or\\r\\n             concurrent biological, chemotherapy, or radiation therapy; (chemotherapy for white\\r\\n             blood count control is permitted)\\r\\n\\r\\n          -  Uncontrolled illness including ongoing or active infection\\r\\n\\r\\n          -  History of allergic reactions attributed to compounds of similar chemical or biologic\\r\\n             composition to etoposide\\r\\n\\r\\n          -  Patients with other active malignancies are ineligible for this study, other than\\r\\n             localized malignancies\\r\\n\\r\\n          -  Patients with psychological or medical condition that patient\\'s physician deems\\r\\n             unacceptable to proceed to allogeneic hematopoietic stem cell transplantation\\r\\n\\r\\n          -  Women who are planning to become pregnant or breast feed during the trial\\r\\n\\r\\n          -  Subjects, who in the opinion of the investigator, may not be able to comply with the\\r\\n             safety monitoring requirements of the study\\r\\n      ', metadata={'disease_category': 'leukemia', 'diseases': \"['adult acute myeloid leukemia with 11q23 (mll) abnormalities', 'adult acute myeloid leukemia with del(5q)', 'adult acute myeloid leukemia with inv(16)(p13;q22)', 'adult acute myeloid leukemia with t(15;17)(q22;q12)', 'adult acute myeloid leukemia with t(16;16)(p13;q22)', 'adult acute myeloid leukemia with t(8;21)(q22;q22)', 'recurrent adult acute lymphoblastic leukemia', 'recurrent adult acute myeloid leukemia', 'recurrent childhood acute lymphoblastic leukemia', 'recurrent childhood acute myeloid leukemia']\", 'drugs': \"['etoposide', 'cyclophosphamide']\", 'nctid': 'NCT02094794', 'status': 'recruiting'})]"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "question = f\"\"\"\n",
    "Which trials are relevant to the patient with the following medical history?\\n\n",
    "patient_profile: {patient_profile}\n",
    "\"\"\"\n",
    "# patient_profile: {patient_profile}\n",
    "# question = \"\"\"\n",
    "# Which trials are relevant to the patient with the medical history of myeloid leukemia?\n",
    "# \"\"\"\n",
    "nprint(question)\n",
    "\n",
    "# docs_retrieved = retriever_trials.get_relevant_documents(question)\n",
    "docs_retrieved = retriever_trial_sq.get_relevant_documents(question)\n",
    "print(len(docs_retrieved))\n",
    "doc_txt = docs_retrieved[0].page_content[:]\n",
    "nctid = docs_retrieved[0].metadata['nctid']\n",
    "for doc in docs_retrieved:\n",
    "    diseases = doc.metadata['diseases']\n",
    "    disease_category = doc.metadata['disease_category']\n",
    "    print(disease_category, diseases)\n",
    "docs_retrieved"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "        Inclusion Criteria:\n",
      "\n",
      "          -  Participant has the ability and the willingness to sign the informed consent document\n",
      "             (for adults only, for participants with mild cognitive abilities may use a legally\n",
      "             authorized representative)\n",
      "\n",
      "          -  Documented (signed) informed consent; the patient, family member and transplant staff\n",
      "             physician (physician, nurse, and social worker) meet at least once prior to starting\n",
      "             the transplant procedure; during this meeting all pertinent information with respect\n",
      "             to risks and benefits to donor and recipient will be presented; alternative treatment\n",
      "             modalities will be discussed; the risks are explained in detail in the enclosed\n",
      "             consent forms\n",
      "\n",
      "          -  Karnofsky performance status >= 70% =< 2\n",
      "\n",
      "          -  Acute lymphocytic leukemia or acute myelogenous leukemia who are not in first\n",
      "             remission or second remission i.e. after failing induction therapy, or in relapse or\n",
      "             beyond second remission; (prior therapy with VP-16 and Cytoxan is allowed)\n",
      "\n",
      "          -  All candidates for this study must have a human leukocyte antigen (HLA) (A, B, C, DR)\n",
      "             identical siblings who is willing to donate bone marrow or primed blood stem cells or\n",
      "             a 10/10 allele matched unrelated donor; a single allele mismatch at A, B, C, DR or DQ\n",
      "             and a killer immunoglobulin-like receptor (KIR) mismatch at C will be allowed; all ABO\n",
      "             blood group combinations of the donor/recipient are acceptable\n",
      "\n",
      "          -  The time from the end last induction, re-induction, or consolidation regimen should be\n",
      "             greater than or equal to 14 days from planned start of study treatment; Note:\n",
      "             Chemotherapy given within 14 days of planned study enrollment for the purpose of\n",
      "             controlling counts is permitted\n",
      "\n",
      "          -  Total bilirubin =< 1.5 x upper limit of normal (ULN) OR 3 x ULN for Gilbert's disease\n",
      "\n",
      "          -  Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate\n",
      "             transaminase (SGPT) =< 5 x ULN\n",
      "\n",
      "          -  Measured creatinine clearance >= 80 ml/min per 24 hour urine collection OR serum\n",
      "             creatinine =< 1.3 mg/dL\n",
      "\n",
      "          -  Women of child bearing potential only: Negative urine or serum pregnancy test\n",
      "\n",
      "          -  Pulmonary function tests: Forced expiratory volume in one second (FEV1) and carbon\n",
      "             monoxide diffusion capacity (DLCO) (adjusted for Hb) >= 50% adjusted of predicted\n",
      "             normal value\n",
      "\n",
      "          -  Echocardiogram (ECHO) or multi gated acquisition scan (MUGA): ejection fraction of >=\n",
      "             50% AND no finding of abnormal wall motion (i.e. report does not indicate that wall\n",
      "             motion is \"abnormal\" or \"altered\")\n",
      "\n",
      "          -  Electrocardiogram (EKG) showing no ischemic changes and no abnormal rhythm\n",
      "\n",
      "          -  Agreement of men AND women-of-child-bearing-potential to use adequate contraception\n",
      "             (hormonal or barrier method of birth control or abstinence) prior to study entry and\n",
      "             for six months following duration of study participation; should a woman become\n",
      "             pregnant or suspect that she is pregnant while participating on the trial, she should\n",
      "             inform her treating physician immediately\n",
      "\n",
      "          -  DONOR ELIGIBILITY: Donor evaluation and eligibility will be assessed as per current\n",
      "             City of Hope standard operating procedure (SOP)\n",
      "\n",
      "        Exclusion Criteria:\n",
      "\n",
      "          -  Prior autologous or allogeneic hematopoietic stem cell\n",
      "\n",
      "          -  Prior radiation therapy that would exclude the use of TMLI\n",
      "\n",
      "          -  Plans during the trial to receive any other (non-trial) investigational agents, or\n",
      "             concurrent biological, chemotherapy, or radiation therapy; (chemotherapy for white\n",
      "             blood count control is permitted)\n",
      "\n",
      "          -  Uncontrolled illness including ongoing or active infection\n",
      "\n",
      "          -  History of allergic reactions attributed to compounds of similar chemical or biologic\n",
      "             composition to etoposide\n",
      "\n",
      "          -  Patients with other active malignancies are ineligible for this study, other than\n",
      "             localized malignancies\n",
      "\n",
      "          -  Patients with psychological or medical condition that patient's physician deems\n",
      "             unacceptable to proceed to allogeneic hematopoietic stem cell transplantation\n",
      "\n",
      "          -  Women who are planning to become pregnant or breast feed during the trial\n",
      "\n",
      "          -  Subjects, who in the opinion of the investigator, may not be able to comply with the\n",
      "             safety monitoring requirements of the study\n",
      "      \n"
     ]
    }
   ],
   "source": [
    "print(docs_retrieved[2].page_content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "# from langchain_community.chat_models import ChatOpenAI\n",
    "from langchain.chains.combine_documents import create_stuff_documents_chain\n",
    "from langchain.chains import create_retrieval_chain\n",
    "from langchain import hub\n",
    "\n",
    "retrieval_qa_chat_prompt = PromptTemplate(\n",
    "    template=\"\"\" You are a Principal Investigator (PI) for evaluating patients for clinical trials. \n",
    "    Use the following retrieved regulations from the institution's policies to answer the question about the patient's eligibility. \n",
    "    Here are the retrieved policies: \\n\\n {context} \\n\\n\n",
    "    Based on the retrieved trial policies, does the following patient profile eligible for clinical trials?\\n\n",
    "    {input} \\n    \n",
    "    Give a reason only to rejection cases.\n",
    "    Give a binary score 'yes' or 'no' score to indicate whether the patient is eligible for clinical trials.\"\"\",\n",
    "    input_variables=[\"context\", \"input\"],\n",
    ")\n",
    "# Today is {date}\\n\n",
    "retrieval_qa_chat_prompt = hub.pull(\"langchain-ai/retrieval-qa-chat\")\n",
    "# llm = ChatOpenAI()\n",
    "# retriever = ...\n",
    "combine_docs_chain = create_stuff_documents_chain(\n",
    "    model, retrieval_qa_chat_prompt\n",
    ")\n",
    "retrieval_chain = create_retrieval_chain(retriever, combine_docs_chain)\n",
    "\n",
    "question = f\"\"\"\n",
    "Does the following patient profile comply with the institutional policies?\\n\n",
    "{patient_profile}\n",
    "\"\"\"\n",
    "\n",
    "# result = retrieval_chain.invoke({\"input\": patient_profile})\n",
    "# nprint(result['answer'])\n",
    "# retrieval_chain.invoke({\"input\": question})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "from langchain import hub\n",
    "from langchain_core.pydantic_v1 import BaseModel, Field\n",
    "\n",
    "from langchain.prompts import PromptTemplate\n",
    "from operator import itemgetter\n",
    "\n",
    "# patient_profile = patient_data_to_string(patient_data)\n",
    "\n",
    "# print(patient_profile)\n",
    "\n",
    "\n",
    "question = f\"\"\"\n",
    "Does the following patient profile comply with the institutional policies?\\n\n",
    "{patient_profile}\n",
    "\"\"\"\n",
    "\n",
    "# prompt = hub.pull(\"rlm/rag-prompt\").pretty_print()  # Show what the prompt looks like\n",
    "\n",
    "from langchain.chains import RetrievalQA\n",
    "\n",
    "\n",
    "class comply(BaseModel):\n",
    "        \"\"\"Binary score for trial eligibility check.\"\"\"\n",
    "\n",
    "        binary_score: str = Field(description=\"Patient eligible for the clinical trial 'yes' or 'no'\")\n",
    "        reason: str = Field(description=\"Reason(s) only if the patient is not eligible for clinical trials. Othereise use NA\")\n",
    "        \n",
    "# model = ChatOpenAI(temperature = 0.0, model=modelID)\n",
    "llm_with_tool = model.with_structured_output(comply)\n",
    "# qa = RetrievalQA.from_chain_type(\n",
    "#     llm=llm_with_tool,\n",
    "#     chain_type=\"stuff\",\n",
    "#     retriever=retriever,\n",
    "# )\n",
    "\n",
    "# completion_chroma = qa.run(question)\n",
    "docs_retrieved = retriever.get_relevant_documents(question)\n",
    "docs_retrieved\n",
    "\n",
    "\n",
    "# completion = qa.run(question)\n",
    "# completion\n",
    "docs_retrieved = retriever.get_relevant_documents(question)\n",
    "docs = \"\\n\\n\".join(doc.page_content for doc in docs_retrieved)\n",
    "docs\n",
    "\n",
    "prompt = PromptTemplate(\n",
    "    template=\"\"\" You are a Principal Investigator (PI) for evaluating patients for clinical trials. \n",
    "    Use the following pieces of retrieved context from the institution's policies to answer the question about the patient's eligibility. \n",
    "    Here are the retrieved policies: \\n\\n {context} \\n\\n\n",
    "    Here is the user question: {question} \\n\n",
    "    Today is {date}\\n\n",
    "    Give a reason only to rejection cases.\n",
    "    Give a binary score 'yes' or 'no' score to indicate whether the patient is eligible for clinical trials.\"\"\",\n",
    "    input_variables=[\"context\", \"question\"],\n",
    ")\n",
    "\n",
    "date = datetime.now().strftime(\"%Y-%m-%d\")\n",
    "\n",
    "# prompt = hub.pull(\"rlm/rag-prompt\").pretty_print()  # Show what the prompt looks like\n",
    "\n",
    "\n",
    "# llm_with_tool = model.with_structured_output(comply)\n",
    "\n",
    "# chain = prompt | model\n",
    "# chain = prompt | llm_with_tool\n",
    "chain = ( \n",
    "    {\"patient_profile\" : chain_profile, \"question\" : itemgetter('question'),\n",
    "     \"context\" : itemgetter('context'), \"date\" : itemgetter('date')} | prompt | llm_with_tool\n",
    ")\n",
    "\n",
    "# scored_result = chain.invoke(\n",
    "#     {\n",
    "#         \"question\": question, \n",
    "#         \"context\": docs, \n",
    "#         \"date\": date, \n",
    "#         \"patient_data\": patient_data\n",
    "#     }\n",
    "# )\n",
    "# scored_result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "def lookup_policy(query: str) -> str:\n",
    "    \"\"\"Consult the company policies to check whether certain options are permitted.\n",
    "    Use this before making any flight changes performing other 'write' events.\"\"\"\n",
    "    docs = retriever.query(query, k=2)\n",
    "    return \"\\n\\n\".join([doc[\"page_content\"] for doc in docs])\n",
    "\n",
    "\n",
    "from langchain.tools.retriever import create_retriever_tool\n",
    "retriever_tool = create_retriever_tool(\n",
    "    retriever,\n",
    "    \"retrieve_institution_policies\",\n",
    "    \"Search and return information about the institution's policies about conducting clinical trials based on the patient's information.\",\n",
    ")\n",
    "\n",
    "tools = [retriever_tool]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# State"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import Annotated, List\n",
    "from typing_extensions import TypedDict\n",
    "from langgraph.graph.message import AnyMessage, add_messages\n",
    "from langchain_core.messages import AIMessage, SystemMessage, HumanMessage, ToolMessage\n",
    "from langchain_core.documents import Document\n",
    "\n",
    "# from typing import TypedDict\n",
    "\n",
    "class AgentState(TypedDict):\n",
    "    patient_prompt: str\n",
    "    patient_id: int\n",
    "    # trials: str\n",
    "    # draft: str\n",
    "    # critique: str\n",
    "    policy_eligible: bool\n",
    "    rejection_reason: str\n",
    "    patient_data: dict\n",
    "    patient_profile: str\n",
    "    revision_number: int\n",
    "    max_revisions: int\n",
    "    policies: List[Document]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Agent"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from langgraph.checkpoint.sqlite import SqliteSaver\n",
    "from langgraph.prebuilt import ToolNode\n",
    "from langgraph.prebuilt import tools_condition\n",
    "from langchain_core.pydantic_v1 import BaseModel\n",
    "\n",
    "# model = ChatOpenAI(model=\"gpt-3.5-turbo\")  #reduce inference cost\n",
    "\n",
    "memory = SqliteSaver.from_conn_string(\":memory:\")\n",
    "\n",
    "\n",
    "\n",
    "# ------- Agents:\n",
    "class Patient_ID(BaseModel):\n",
    "    patient_id: int\n",
    "    # no_id: bool\n",
    "\n",
    "# model = ChatOpenAI(model=\"gpt-3.5-turbo\", temperature=0)  #reduce inference cost\n",
    "patient_data_prompt = \"\"\"You are a helpful assistance in extrcting patient's medical history.\n",
    "Based on the following request identify and return the patient's ID number.\n",
    "\"\"\"\n",
    "# If you cannot find patient ID in the request text then return 10000 as response.\n",
    "\n",
    "def patient_collector_node(state: AgentState):\n",
    "    response = model.with_structured_output(Patient_ID).invoke([\n",
    "        SystemMessage(content=patient_data_prompt),\n",
    "        HumanMessage(content=state['patient_prompt'])\n",
    "    ])\n",
    "    patient_id = response.patient_id\n",
    "    print(response)\n",
    "    print(f\"Patient ID: {patient_id}\")\n",
    "    result = get_patient_data(patient_id)\n",
    "    \n",
    "    return {\n",
    "        \"patient_data\": result,\n",
    "        \"patient_id\": patient_id,\n",
    "        \"revision_number\": state.get(\"revision_number\", 1) + 1\n",
    "        }\n",
    "\n",
    "# Define the agent state structure\n",
    "# class NewPatientData(TypedDict):\n",
    "#     name: str\n",
    "#     age: int\n",
    "#     medical_history: str\n",
    "#     previous_trials: str\n",
    "#     trial_status: str\n",
    "#     last_trial_dates: str\n",
    "\n",
    "\n",
    "# def patient_adder_node(state: AgentState):\n",
    "#     # x= input(\"Enter patient data: \")\n",
    "#     # print(x)\n",
    "#     add_patient_data(\n",
    "#         {\"name\": \"John Doe\", \n",
    "#         \"age\": 45, \n",
    "#         \"medical_history\": \"Hypertension\", \n",
    "#         \"previous_trials\": \"Trial 15\", \n",
    "#         \"trial_status\": \"Completed\", \n",
    "#         \"last_trial_dates\": \"2021-06-14\"}\n",
    "#         )\n",
    "#     print('patient added')    \n",
    "\n",
    "def policy_checker(state: AgentState):\n",
    "    # Convert patient_data to string\n",
    "    \n",
    "    parser = StrOutputParser()\n",
    "    prompt_profile = PromptTemplate(\n",
    "        template=\"\"\"\n",
    "        You are the Clinical Research Coordinator. Use the following patient data to write the patient profile.\n",
    "        Write the patient profile in 3 to 4 sentences.\\n\\n\n",
    "        {patient_data}\"\"\",\n",
    "        input_variables=[\"patient_data\"],\n",
    "    )\n",
    "    # model = ChatOpenAI(temperature = 0.0, model=modelID)\n",
    "\n",
    "    chain_profile = prompt_profile | model | parser\n",
    "    patient_data = state['patient_data']\n",
    "    patient_profile = chain_profile.invoke({'patient_data': patient_data})\n",
    "    # nprint(patient_profile)\n",
    "            \n",
    "    question = f\"\"\"\n",
    "    Does the following patient profile comply with the institutional policies?\\n\n",
    "    {patient_profile}\n",
    "    \"\"\"\n",
    "\n",
    "    class comply(BaseModel):\n",
    "            \"\"\"Binary score for trial eligibility check.\"\"\"\n",
    "\n",
    "            binary_score: str = Field(description=\"Patient eligible for the clinical trial 'yes' or 'no'\")\n",
    "            reason: str = Field(description=\"Reason(s) only if the patient is not eligible for clinical trials. Othereise use NA\")\n",
    "            \n",
    "    # model = ChatOpenAI(temperature = 0.0, model=modelID)\n",
    "    llm_with_tool = model.with_structured_output(comply)\n",
    "    \n",
    "    docs_retrieved = retriever.get_relevant_documents(question)\n",
    "    # docs_retrieved\n",
    "    docs = \"\\n\\n\".join(doc.page_content for doc in docs_retrieved)\n",
    "    # docs\n",
    "\n",
    "    prompt_policy = PromptTemplate(\n",
    "        template=\"\"\" You are a Principal Investigator (PI) for evaluating patients for clinical trials. \n",
    "        Use the following pieces of retrieved context from the institution's policies to answer the question about the patient's eligibility. \n",
    "        Here are the retrieved policies: \\n\\n {context} \\n\\n\n",
    "        Here is the user question: {question} \\n\n",
    "        Today is {date}\\n\n",
    "        Give a reason only to rejection cases.\n",
    "        Give a binary score 'yes' or 'no' score to indicate whether the patient is eligible for clinical trials.\"\"\",\n",
    "        input_variables=[\"context\", \"question\"],\n",
    "    )\n",
    "\n",
    "    date = datetime.now().strftime(\"%Y-%m-%d\")\n",
    "    \n",
    "    chain = ( \n",
    "        {\"patient_profile\" : chain_profile, \"question\" : itemgetter('question'),\n",
    "        \"context\" : itemgetter('context'), \"date\" : itemgetter('date')} | prompt_policy | llm_with_tool\n",
    "    )\n",
    "\n",
    "    scored_result = chain.invoke(\n",
    "        {\n",
    "            \"question\": question, \n",
    "            \"context\": docs, \n",
    "            \"date\": date, \n",
    "            \"patient_data\": patient_data\n",
    "        }\n",
    "    )\n",
    "    \n",
    "    # scored_result    \n",
    "    state['policy_eligible'] = True\n",
    "    if scored_result.binary_score == 'no':\n",
    "        state['policy_eligible'] = False    \n",
    "        state['rejection_reason'] = scored_result.reason\n",
    "    \n",
    "    state['policies'] = docs_retrieved\n",
    "    state['patient_profile'] = patient_profile\n",
    "\n",
    "    return state\n",
    "\n",
    "def should_continue(state: AgentState):\n",
    "    end = False\n",
    "    if state.get(\"patient_data\"):\n",
    "        print('patient data found')\n",
    "        print(state.get(\"patient_data\"))\n",
    "        return \"policy_checker\"\n",
    "    else:\n",
    "        print('patient data not found')\n",
    "        return END\n",
    "        \n",
    "    if state[\"revision_number\"] > state[\"max_revisions\"]:\n",
    "        print('max revision reached')\n",
    "        # print(state.get(\"patient_data\", 1))\n",
    "        return END        \n",
    "\n",
    "\n",
    "# ==== define graph nodes====\n",
    "from langgraph.graph import StateGraph, END\n",
    "\n",
    "builder = StateGraph(AgentState)\n",
    "builder.set_entry_point(\"patient_collector\")\n",
    "\n",
    "builder.add_node(\"patient_collector\", patient_collector_node)\n",
    "builder.add_node(\"policy_checker\", policy_checker)\n",
    "\n",
    "# retrieve = ToolNode([retriever_tool])\n",
    "# builder.add_node(\"retrieve\", retrieve)  # retrieval\n",
    "\n",
    "\n",
    "# ===== define graph edges====\n",
    "# builder.add_edge(\"patient_collector\", \"\")\n",
    "# builder.add_edge(\"patient_adder\", \"patient_collector\")\n",
    "builder.add_conditional_edges(\n",
    "    \"patient_collector\", \n",
    "    should_continue, \n",
    "    {END: END\n",
    "    # \"patient_collector\": \"patient_collector\"\n",
    "    , \"policy_checker\": \"policy_checker\"\n",
    "    # ,\"patient_adder\": \"patient_adder\"\n",
    "    }\n",
    ")\n",
    "\n",
    "# builder.add_edge(\"policy_checker\", \"retrieve\")\n",
    "# builder.add_conditional_edges(\n",
    "#     \"policy_checker\", \n",
    "#     tools_condition, \n",
    "#     {END: END\n",
    "#     ,\"tools\": \"retrieve\"\n",
    "#     }\n",
    "# )\n",
    "\n",
    "builder.add_edge(\"policy_checker\", END)\n",
    "\n",
    "\n",
    "graph = builder.compile(\n",
    "    checkpointer=memory\n",
    "    # , interrupt_before=[\"patient_adder\"]\n",
    ")\n",
    "\n",
    "from IPython.display import Image\n",
    "\n",
    "Image(graph.get_graph().draw_png())\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'patient_id': 8,\n",
       " 'name': 'Daniel Wilson',\n",
       " 'age': 21,\n",
       " 'medical_history': 'Cancer',\n",
       " 'previous_trials': 'Trial 12',\n",
       " 'trial_status': 'Ongoing',\n",
       " 'trial_completion_date': None}"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# patient_data['medical_history'] = \"Chronic Pain, Pregnant\"\n",
    "sample_patient_id = 8\n",
    "patient_data = get_patient_data(sample_patient_id)\n",
    "# patient_data['trial_completion_date'] = '2024-04-01'\n",
    "patient_data\n",
    "# date"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "patient_id=8\n",
      "Patient ID: 8\n",
      "patient data found\n",
      "{'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}\n",
      "{'patient_collector': {'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'revision_number': 2}}\n",
      "{'policy_checker': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'policy_eligible': False, 'rejection_reason': 'Patient has a medical history of cancer, currently enrolled in an ongoing trial, and has previously participated in Trial 12. The patient is not eligible for clinical trials due to the medical history and ongoing trial enrollment.', 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'patient_profile': 'Patient 8, Daniel Wilson, is a 21-year-old individual with a medical history of cancer. He has previously participated in Trial 12 and is currently enrolled in an ongoing trial. The trial completion date for Daniel is not yet determined.', 'revision_number': 2, 'max_revisions': 2, 'policies': [Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 8. **Travel Restrictions**\\n   - **Travel Requirements**: Patients must be able to travel to the trial site regularly for check-ups and monitoring without significant hardship or risk.\\n   - **Travel History**: Patients who have traveled to areas with active outbreaks of infectious diseases within the past 3 months are not eligible.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}}\n"
     ]
    }
   ],
   "source": [
    "thread = {\"configurable\": {\"thread_id\": \"9\"}}\n",
    "for s in graph.stream({\n",
    "    'patient_prompt': f\"Is patient {sample_patient_id} eligible for any medical trial?\",\n",
    "    # 'patient_prompt': \"Is patient Max eligible for any medical trial?\",\n",
    "    \"max_revisions\": 2,\n",
    "    \"revision_number\": 1,\n",
    "}, thread):\n",
    "    print(s)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "StateSnapshot(values={'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'policy_eligible': False, 'rejection_reason': 'History of cancer and previous participation in Trial 12 within an unknown trial status and completion date.', 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': None, 'trial_completion_date': None}, 'patient_profile': \"Patient Profile:\\nDaniel Wilson is a 21-year-old individual with a history of cancer. He has previously participated in Trial 12. Currently, Daniel's trial status and trial completion date are unknown. As the Clinical Research Coordinator, I will ensure that Daniel receives the necessary care and support throughout his participation in the clinical trial.\", 'revision_number': 2, 'max_revisions': 2, 'policies': [Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 6. **Special Considerations**\\n   - **Pregnancy and Nursing**: Pregnant or nursing women are excluded unless the trial is specifically designed for this population.\\n   - **Genetic Testing**: Trials involving genetic testing must have explicit consent from patients for genetic data collection and analysis.\\n   - **Patient Monitoring**: Patients must agree to regular monitoring and follow-up visits as specified by the trial protocol.\\n   - **BMI Restrictions**: Patients with a BMI outside the range of 18.5-35 may be excluded unless otherwise specified.\\n   - **Comorbid Conditions**: Patients with multiple comorbid conditions that may interfere with the study outcomes are excluded.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}, next=(), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef30790-f65f-67f7-8004-eb99d95d7f2f'}}, metadata={'source': 'loop', 'step': 4, 'writes': {'policy_checker': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'policy_eligible': False, 'rejection_reason': 'History of cancer and previous participation in Trial 12 within an unknown trial status and completion date.', 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': None, 'trial_completion_date': None}, 'patient_profile': \"Patient Profile:\\nDaniel Wilson is a 21-year-old individual with a history of cancer. He has previously participated in Trial 12. Currently, Daniel's trial status and trial completion date are unknown. As the Clinical Research Coordinator, I will ensure that Daniel receives the necessary care and support throughout his participation in the clinical trial.\", 'revision_number': 2, 'max_revisions': 2, 'policies': [Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 6. **Special Considerations**\\n   - **Pregnancy and Nursing**: Pregnant or nursing women are excluded unless the trial is specifically designed for this population.\\n   - **Genetic Testing**: Trials involving genetic testing must have explicit consent from patients for genetic data collection and analysis.\\n   - **Patient Monitoring**: Patients must agree to regular monitoring and follow-up visits as specified by the trial protocol.\\n   - **BMI Restrictions**: Patients with a BMI outside the range of 18.5-35 may be excluded unless otherwise specified.\\n   - **Comorbid Conditions**: Patients with multiple comorbid conditions that may interfere with the study outcomes are excluded.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}}}, created_at='2024-06-22T09:23:17.929163+00:00', parent_config={'configurable': {'thread_id': '9', 'thread_ts': '1ef30790-4cc6-67ad-8003-cddadf3343fb'}})\n",
      "--\n",
      "StateSnapshot(values={'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': None, 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}, next=('policy_checker',), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef30790-4cc6-67ad-8003-cddadf3343fb'}}, metadata={'source': 'update', 'step': 3, 'writes': {'patient_collector': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': None, 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}}}, created_at='2024-06-22T09:23:00.145553+00:00', parent_config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078d-5a56-60cf-8002-9acd520c48ce'}})\n",
      "--\n",
      "StateSnapshot(values={'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}, next=('policy_checker',), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078e-1e02-6b1a-8002-6bc265a2d459'}}, metadata={'source': 'update', 'step': 2, 'writes': {'patient_collector': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}}}, created_at='2024-06-22T09:22:01.554818+00:00', parent_config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-462f-6d07-8001-3f6bf605c337'}})\n",
      "--\n",
      "StateSnapshot(values={'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}, next=('policy_checker',), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078d-5a56-60cf-8002-9acd520c48ce'}}, metadata={'source': 'update', 'step': 2, 'writes': {'patient_collector': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}}}, created_at='2024-06-22T09:21:41.036871+00:00', parent_config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-462f-6d07-8001-3f6bf605c337'}})\n",
      "--\n",
      "StateSnapshot(values={'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'policy_eligible': False, 'rejection_reason': 'Patient has a medical history of cancer, currently enrolled in an ongoing trial, and has previously participated in Trial 12. The patient is not eligible for clinical trials due to the medical history and ongoing trial enrollment.', 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'patient_profile': 'Patient 8, Daniel Wilson, is a 21-year-old individual with a medical history of cancer. He has previously participated in Trial 12 and is currently enrolled in an ongoing trial. The trial completion date for Daniel is not yet determined.', 'revision_number': 2, 'max_revisions': 2, 'policies': [Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 8. **Travel Restrictions**\\n   - **Travel Requirements**: Patients must be able to travel to the trial site regularly for check-ups and monitoring without significant hardship or risk.\\n   - **Travel History**: Patients who have traveled to areas with active outbreaks of infectious diseases within the past 3 months are not eligible.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}, next=(), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-6af6-6372-8002-8a41f61add3d'}}, metadata={'source': 'loop', 'step': 2, 'writes': {'policy_checker': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'policy_eligible': False, 'rejection_reason': 'Patient has a medical history of cancer, currently enrolled in an ongoing trial, and has previously participated in Trial 12. The patient is not eligible for clinical trials due to the medical history and ongoing trial enrollment.', 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'patient_profile': 'Patient 8, Daniel Wilson, is a 21-year-old individual with a medical history of cancer. He has previously participated in Trial 12 and is currently enrolled in an ongoing trial. The trial completion date for Daniel is not yet determined.', 'revision_number': 2, 'max_revisions': 2, 'policies': [Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 8. **Travel Restrictions**\\n   - **Travel Requirements**: Patients must be able to travel to the trial site regularly for check-ups and monitoring without significant hardship or risk.\\n   - **Travel History**: Patients who have traveled to areas with active outbreaks of infectious diseases within the past 3 months are not eligible.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}}}, created_at='2024-06-22T09:21:15.936651+00:00', parent_config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-462f-6d07-8001-3f6bf605c337'}})\n",
      "--\n",
      "StateSnapshot(values={'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}, next=('policy_checker',), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-462f-6d07-8001-3f6bf605c337'}}, metadata={'source': 'loop', 'step': 1, 'writes': {'patient_collector': {'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'revision_number': 2}}}, created_at='2024-06-22T09:21:12.080512+00:00', parent_config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-3c1c-6937-8000-df9a8f7267d5'}})\n",
      "--\n",
      "StateSnapshot(values={'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'revision_number': 1, 'max_revisions': 2}, next=('patient_collector',), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-3c1c-6937-8000-df9a8f7267d5'}}, metadata={'source': 'loop', 'step': 0, 'writes': None}, created_at='2024-06-22T09:21:11.024056+00:00', parent_config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-3bf1-64dc-bfff-d6f5fe45f8e0'}})\n",
      "--\n",
      "StateSnapshot(values={}, next=('__start__',), config={'configurable': {'thread_id': '9', 'thread_ts': '1ef3078c-3bf1-64dc-bfff-d6f5fe45f8e0'}}, metadata={'source': 'input', 'step': -1, 'writes': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'max_revisions': 2, 'revision_number': 1}}, created_at='2024-06-22T09:21:11.006332+00:00', parent_config=None)\n",
      "--\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'patient_prompt': 'Is patient 8 eligible for any medical trial?',\n",
       " 'patient_id': 8,\n",
       " 'policy_eligible': False,\n",
       " 'rejection_reason': 'History of cancer and previous participation in Trial 12 within an unknown trial status and completion date.',\n",
       " 'patient_data': {'patient_id': 8,\n",
       "  'name': 'Daniel Wilson',\n",
       "  'age': 21,\n",
       "  'medical_history': 'Cancer',\n",
       "  'previous_trials': 'Trial 12',\n",
       "  'trial_status': None,\n",
       "  'trial_completion_date': None},\n",
       " 'patient_profile': \"Patient Profile:\\nDaniel Wilson is a 21-year-old individual with a history of cancer. He has previously participated in Trial 12. Currently, Daniel's trial status and trial completion date are unknown. As the Clinical Research Coordinator, I will ensure that Daniel receives the necessary care and support throughout his participation in the clinical trial.\",\n",
       " 'revision_number': 2,\n",
       " 'max_revisions': 2,\n",
       " 'policies': [Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       "  Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       "  Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       "  Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       "  Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}),\n",
       "  Document(page_content='\\n#### 6. **Special Considerations**\\n   - **Pregnancy and Nursing**: Pregnant or nursing women are excluded unless the trial is specifically designed for this population.\\n   - **Genetic Testing**: Trials involving genetic testing must have explicit consent from patients for genetic data collection and analysis.\\n   - **Patient Monitoring**: Patients must agree to regular monitoring and follow-up visits as specified by the trial protocol.\\n   - **BMI Restrictions**: Patients with a BMI outside the range of 18.5-35 may be excluded unless otherwise specified.\\n   - **Comorbid Conditions**: Patients with multiple comorbid conditions that may interfere with the study outcomes are excluded.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "states = []\n",
    "for state in graph.get_state_history(thread):\n",
    "    print(state)\n",
    "    print('--')\n",
    "    states.append(state)\n",
    "state = states[0]\n",
    "state.values    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "policy_checker\n",
      "{'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'policy_eligible': False, 'rejection_reason': 'Patient has a medical history of cancer, currently enrolled in an ongoing trial, and has previously participated in Trial 12. The patient is not eligible for clinical trials due to the medical history and ongoing trial enrollment.', 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': 'Ongoing', 'trial_completion_date': None}, 'patient_profile': 'Patient 8, Daniel Wilson, is a 21-year-old individual with a medical history of cancer. He has previously participated in Trial 12 and is currently enrolled in an ongoing trial. The trial completion date for Daniel is not yet determined.', 'revision_number': 2, 'max_revisions': 2, 'policies': [Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 8. **Travel Restrictions**\\n   - **Travel Requirements**: Patients must be able to travel to the trial site regularly for check-ups and monitoring without significant hardship or risk.\\n   - **Travel History**: Patients who have traveled to areas with active outbreaks of infectious diseases within the past 3 months are not eligible.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}\n"
     ]
    }
   ],
   "source": [
    "for k, v in s.items():\n",
    "    if k != \"__end__\":\n",
    "        print(k)\n",
    "        print(v)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## HIL\n",
    "To correct Patient's data to pass the eligibility check."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': None, 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}\n",
      "('policy_checker',)\n",
      "{'configurable': {'thread_id': '9', 'thread_ts': '1ef30790-4cc6-67ad-8003-cddadf3343fb'}}\n",
      "{'source': 'update', 'step': 3, 'writes': {'patient_collector': {'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': 'Trial 12', 'trial_status': None, 'trial_completion_date': None}, 'revision_number': 2, 'max_revisions': 2}}}\n",
      "2024-06-22T09:23:00.145553+00:00\n",
      "{'configurable': {'thread_id': '9', 'thread_ts': '1ef3078d-5a56-60cf-8002-9acd520c48ce'}}\n",
      "patient data found\n",
      "{'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': None, 'trial_status': None, 'trial_completion_date': None}\n",
      "{'configurable': {'thread_id': '9', 'thread_ts': '1ef30793-46e6-6923-8004-95b2cdba3766'}}\n",
      "--------- continue from modified state ---------\n",
      "{'patient_prompt': 'Is patient 8 eligible for any medical trial?', 'patient_id': 8, 'policy_eligible': False, 'rejection_reason': 'Active cancer is an exclusion criteria unless the trial specifically addresses this condition.', 'patient_data': {'patient_id': 8, 'name': 'Daniel Wilson', 'age': 21, 'medical_history': 'Cancer', 'previous_trials': None, 'trial_status': None, 'trial_completion_date': None}, 'patient_profile': 'Patient Profile:\\nDaniel Wilson is a 21-year-old individual with a history of cancer. He has not participated in any previous clinical trials and currently does not have any ongoing trial participation. His trial completion date is also not available at this time.', 'revision_number': 2, 'max_revisions': 2, 'policies': [Document(page_content='\\n#### 2. **Medical History Restrictions**\\n   - **Chronic Conditions**:\\n     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)\\n     - Uncontrolled Diabetes Mellitus\\n     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)\\n   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.\\n   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.\\n   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 1. **General Eligibility Criteria**\\n   - **Age Restrictions**: Patients must be between 18 and 75 years old.\\n   - **Gender**: No restrictions unless specified by the trial protocol.\\n   - **Informed Consent**: All patients must provide informed consent prior to participation.\\n   - **Residency**: Patients must be residents of the country where the trial is conducted.\\n   - **Health Insurance**: Patients must have valid health insurance coverage.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 4. **Medication and Treatment Restrictions**\\n   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.\\n   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.\\n   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 3. **Previous Trial Participation**\\n   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.\\n   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.\\n   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.\\n   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the least 5 months prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.\\n   - **Trial Outcomes**:\\n     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.\\n     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 8. **Travel Restrictions**\\n   - **Travel Requirements**: Patients must be able to travel to the trial site regularly for check-ups and monitoring without significant hardship or risk.\\n   - **Travel History**: Patients who have traveled to areas with active outbreaks of infectious diseases within the past 3 months are not eligible.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'}), Document(page_content='\\n#### 5. **Regulatory Compliance**\\n   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.\\n   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).\\n   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.\\n', metadata={'source': '../../source_data/instut_trials_policy.md'})]}\n"
     ]
    }
   ],
   "source": [
    "state = states[1]\n",
    "for k in state:\n",
    "    print(k)\n",
    "\n",
    "state.values[\"patient_data\"]['trial_status'] = None\n",
    "state.values[\"patient_data\"]['previous_trials'] = None\n",
    "branch_state = graph.update_state(state.config, state.values)\n",
    "print(branch_state)\n",
    "# state\n",
    "\n",
    "\n",
    "print(\"--------- continue from modified state ---------\")\n",
    "for event in graph.stream(None, branch_state):\n",
    "    for k, v in event.items():\n",
    "        if k != \"__end__\":\n",
    "            print(v)\n",
    "\n",
    "# for event in graph.stream({\n",
    "#     'patient_prompt': f\"Is patient {sample_patient_id} eligible for any medical trial?\",\n",
    "#     # 'patient_prompt': \"Is patient Max eligible for any medical trial?\",\n",
    "#     \"max_revisions\": 2,\n",
    "#     \"revision_number\": 1,\n",
    "# }, thread):\n",
    "#     print(event)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "patient data not found --> patient_adder_node\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'configurable': {'thread_id': '1',\n",
       "  'thread_ts': '1ef2f4b1-a2ee-6432-8002-173519ee5347'}}"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# s.get(\"patient_collector\")\n",
    "# graph.get_state(thread).next\n",
    "# graph.get_state_history(thread)\n",
    "current_state = graph.get_state(thread)\n",
    "current_state.values[\"patient_prompt\"] = 'Is patient 100 eligible for any medical trial?'\n",
    "graph.update_state(thread, current_state.values)\n",
    "# s\n",
    "# a=10000\n",
    "# type(a)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'configurable': {'thread_id': '1',\n",
       "  'thread_ts': '1ef2f4f7-19d3-601f-8001-87ae15683d5d'}}"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state = states[2]\n",
    "state.values[\"patient_prompt\"] = 'Is patient 100 eligible for any medical trial?'\n",
    "branch_state = graph.update_state(state.config, state.values)\n",
    "branch_state"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "patient_id=100\n",
      "Patient ID: 100\n",
      "patient data found\n",
      "{'patient_id': 100, 'name': 'James Smith', 'age': 61, 'medical_history': 'Anxiety', 'previous_trials': 'Trial 5', 'trial_status': 'Withdrawn', 'last_trial_dates': '2022-08-11'}\n",
      "max revision reached\n",
      "{'patient_data': {'patient_id': 100, 'name': 'James Smith', 'age': 61, 'medical_history': 'Anxiety', 'previous_trials': 'Trial 5', 'trial_status': 'Withdrawn', 'last_trial_dates': '2022-08-11'}, 'revision_number': 2}\n"
     ]
    }
   ],
   "source": [
    "for event in graph.stream(None, branch_state):\n",
    "    for k, v in event.items():\n",
    "        if k != \"__end__\":\n",
    "            print(v)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## =========== GPT way =============="
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "ename": "TypeError",
     "evalue": "StateGraph.__init__() missing 1 required positional argument: 'state_schema'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[3], line 18\u001b[0m\n\u001b[0;32m     15\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcontinue\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m     17\u001b[0m \u001b[38;5;66;03m# Initialize the state graph\u001b[39;00m\n\u001b[1;32m---> 18\u001b[0m workflow \u001b[38;5;241m=\u001b[39m \u001b[43mStateGraph\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m     20\u001b[0m \u001b[38;5;66;03m# Add nodes\u001b[39;00m\n\u001b[0;32m     21\u001b[0m workflow\u001b[38;5;241m.\u001b[39madd_node(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mretrieve_patient_data\u001b[39m\u001b[38;5;124m\"\u001b[39m, call_model)\n",
      "\u001b[1;31mTypeError\u001b[0m: StateGraph.__init__() missing 1 required positional argument: 'state_schema'"
     ]
    }
   ],
   "source": [
    "from langgraph.graph import StateGraph, END\n",
    "from langchain_openai import ChatOpenAI\n",
    "\n",
    "# Define the function that calls the model\n",
    "def call_model(state):\n",
    "    # In this simple example, we just pass the patient_id to the tool and get the patient data\n",
    "    patient_id = state[\"patient_id\"]\n",
    "    patient_data = retrieve_patient_data_tool(patient_id)\n",
    "    return {\"patient_data\": patient_data}\n",
    "\n",
    "# Define the function that determines whether to continue or not\n",
    "def should_continue(state):\n",
    "    if state.get(\"patient_data\"):\n",
    "        return \"end\"\n",
    "    return \"continue\"\n",
    "\n",
    "# Initialize the state graph\n",
    "workflow = StateGraph()\n",
    "\n",
    "# Add nodes\n",
    "workflow.add_node(\"retrieve_patient_data\", call_model)\n",
    "\n",
    "# Set entry point\n",
    "workflow.set_entry_point(\"retrieve_patient_data\")\n",
    "\n",
    "# Define conditional edges\n",
    "workflow.add_conditional_edges(\n",
    "    \"retrieve_patient_data\",\n",
    "    should_continue,\n",
    "    {\"continue\": \"retrieve_patient_data\", \"end\": END}\n",
    ")\n",
    "\n",
    "# Compile the workflow\n",
    "app = workflow.compile()\n",
    "\n",
    "# Example invocation\n",
    "initial_state = {\"patient_id\": 1}\n",
    "app.invoke(initial_state)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Dummy tests"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "     type                  name              tbl_name  rootpage  \\\n",
      "0   table        aircrafts_data        aircrafts_data         2   \n",
      "1   table         airports_data         airports_data         3   \n",
      "2   table       boarding_passes       boarding_passes         4   \n",
      "3   table              bookings              bookings         5   \n",
      "4   table               flights               flights         6   \n",
      "5   table                 seats                 seats         7   \n",
      "6   table        ticket_flights        ticket_flights         8   \n",
      "7   table               tickets               tickets         9   \n",
      "8   table           car_rentals           car_rentals     21958   \n",
      "9   table                hotels                hotels     21961   \n",
      "10  table  trip_recommendations  trip_recommendations     21962   \n",
      "\n",
      "                                                  sql  \n",
      "0   CREATE TABLE \"aircrafts_data\" (\\n\"aircraft_cod...  \n",
      "1   CREATE TABLE \"airports_data\" (\\n\"airport_code\"...  \n",
      "2   CREATE TABLE \"boarding_passes\" (\\n\"ticket_no\" ...  \n",
      "3   CREATE TABLE \"bookings\" (\\n\"book_ref\" TEXT,\\n ...  \n",
      "4   CREATE TABLE \"flights\" (\\n\"flight_id\" INTEGER,...  \n",
      "5   CREATE TABLE \"seats\" (\\n\"aircraft_code\" TEXT,\\...  \n",
      "6   CREATE TABLE \"ticket_flights\" (\\n\"ticket_no\" T...  \n",
      "7   CREATE TABLE \"tickets\" (\\n\"ticket_no\" TEXT,\\n ...  \n",
      "8   CREATE TABLE car_rentals (\\n        id INTEGER...  \n",
      "9   CREATE TABLE hotels (\\n        id INTEGER PRIM...  \n",
      "10  CREATE TABLE trip_recommendations (\\n        i...  \n"
     ]
    }
   ],
   "source": [
    "assert 1==2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "import os\n",
    "import shutil\n",
    "import sqlite3\n",
    "\n",
    "import pandas as pd\n",
    "import requests\n",
    "\n",
    "db_url = \"https://storage.googleapis.com/benchmarks-artifacts/travel-db/travel2.sqlite\"\n",
    "local_file = \"travel2.sqlite\"\n",
    "# The backup lets us restart for each tutorial section\n",
    "backup_file = \"travel2.backup.sqlite\"\n",
    "overwrite = False\n",
    "if overwrite or not os.path.exists(local_file):\n",
    "    response = requests.get(db_url)\n",
    "    response.raise_for_status()  # Ensure the request was successful\n",
    "    with open(local_file, \"wb\") as f:\n",
    "        f.write(response.content)\n",
    "    # Backup - we will use this to \"reset\" our DB in each section\n",
    "    shutil.copy(local_file, backup_file)\n",
    "# Convert the flights to present time for our tutorial\n",
    "# local_file = \n",
    "conn = sqlite3.connect(local_file)\n",
    "cursor = conn.cursor()\n",
    "\n",
    "query = 'SELECT * FROM sqlite_master'\n",
    "\n",
    "# Execute the query and fetch all results\n",
    "cursor.execute(query)\n",
    "rows = cursor.fetchall()\n",
    "\n",
    "# Optionally, you can get the column names\n",
    "column_names = [description[0] for description in cursor.description]\n",
    "\n",
    "# Convert the results to a Pandas DataFrame for better readability\n",
    "df = pd.DataFrame(rows, columns=column_names)\n",
    "\n",
    "# Display the DataFrame\n",
    "print(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'tdf' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[6], line 1\u001b[0m\n\u001b[1;32m----> 1\u001b[0m \u001b[43mtdf\u001b[49m\n",
      "\u001b[1;31mNameError\u001b[0m: name 'tdf' is not defined"
     ]
    }
   ],
   "source": [
    "tdf"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".llmenv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
